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1 Background 
The goal of the experiments described below was to show the impact of extracellular 
nucleotides on immunological effector functions of macrophages in experimental 
models of sepsis. 
In this first chapter, I am going to introduce the reader shortly into the general topic 
and the specific ideas of this work. The clinical and cellular background of this basic 
research project are explained. Further, the clinical problem of sepsis, a clinical 
situation that is difficult to handle, its social importance and its mechanisms are 
introduced. Subsequently I am introducing into the mechanisms of purinergic 
signaling, and signaling induced by endotoxins, which are the basic principles of this 
work. Thereby, I am focusing on the interactions of purinergic signaling, 
macrophages, and bacterial infection. Furthermore, I am going to explain the 
questions, ideas and designs of our experimental approach with their expected 
effects – whether or not they were observed.  
At the end of this chapter, the reader should be able to follow the reasons and 
designs of this work, and the series of experiments described afterwards. 
1.1 Sepsis  
1.1.1 Sepsis as a medical challenge 
Bacterial sepsis is, due to the very complex and self-energizing signaling cascades 
later described in more detail, a very severe clinical condition, which can finally lead 
to severe sepsis, septic shock, and death. The complex pathophysiology of sepsis is 
not yet fully understood because of very complex interactions between 
microorganisms, the immune system and the diverse organs (Castelheim, 2009) 
(Kumar, 2007). All this makes bacterial sepsis and endotoxemia very difficult to treat.  
Furthermore sepsis is a possible and potentially lethal complication. In surgery, where 
infections are an omnipresent clinical problem to be prevented and treated, 
abdominal sepsis represents a frequent indication for abdominal exploration. In 
particular in visceral surgery that represents surgery in a contaminated area further 
insight into pathophysiological mechanisms of sepsis may have clinical implications. 
Furthermore, sepsis is a common problem in hospitals and in intensive care units 
associated with significant socio-economic consequences (Angus, 2001) (Vincent, 
2006). 
The very general motivation for this work therefore is trying to further explore one of 
the mechanisms of sepsis, in particular the role of extracellular nucleotides.  
1.1.2 General mechanisms of sepsis 
Lipopolysaccharides (LPS) are endotoxins, a toxic component of the outer cell 
membrane of gram-negative bacteria (Castelheim, 2009) (Kumar, 2007). When gram-
negative bacteria are destroyed, LPS are released. This normally happens when 
gram-negative bacteria are fought by the immune response of the host. Bacterial 
infections by gram-negative bacteria can therefore lead to a release of LPS into the 
blood, called endotoxemia. 
LPS lead to an activation of the membrane bound Toll-like-Receptors (TLRs) on 
various cell types, macrophages amongst others. The activation of TLR on 
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macrophages directly and indirectly leads to a release of diverse cytokines (e.g. TNF, 
IL-6). These cytokines act as modulators/promoters of the immune system and many 
other organs such as the vasculature. Together these cytokines are able to induce a 
vicious circle. An extensive release of such cytokines – a cytokine storm – can lead to 
systemic inflammation, sepsis, septic shock, and dead. 
One difficulty in the clinical treatment of sepsis is to manage the dangerous effect of a 
cytokine release in response to endotoxemia, as described above. If it is possible in a 
one-cell-type-model (e.g. as described in the last passage) to diminish or even 
abolish – using extracellular nucleotides – the cytokine release provoked by LPS, this 
may also be possible in the entire organisms. The first we describe in our experiments 
with Kupffer cells. The latter, on the other hand could be possible either by applying 
nucleotides directly – for example in the systemic circulation by intravenous injection 
– or by finding a mechanism to let the organism do the same thing itself. 
1.1.3 Social importance of sepsis 
Two studies (Vincent, 2006) (Angus, 2001) in the United States and Europe underline 
that sepsis is a serious issue in health care concerning both mortality and costs. 
Furthermore, the study in the USA shows that sepsis is a problem of the elderly, and 
with the demographic change therefore of increasing importance, as shown by some 
selected data of these studies. 
1.1.3.1 SOAP (Sepsis Occurrence in Acutely Ill Patients) study (Europe) (Vincent, 
2006):  
• 37% of ICU patients had identified infection with a high variability between 
countries (18-73%). 
• ICU mortality rate in patients with sepsis was greater than in those without 
sepsis (27 vs. 14%).  
• In patients with severe sepsis the ICU mortality rate was 32.2% and in those 
with septic shock 54.1%. 
• There was a correlation between ICU mortality rate and sepsis rate in ICU 
patients in different countries. 
• There is an inverse correlation between the number of organs failing and 
mortality in severe sepsis. 
1.1.3.2 Epidemiology of severe sepsis (US): (Angus, 2001) 
• 2.1-4.3% of hospital admissions had severe sepsis with a mean age of 64.8 
years.  
• 58% of patients with severe sepsis were admitted to ICU.  
• Half of the patients with severe sepsis were 65 years or older. 
• The incidence rate increased in the elderly aged 85 years or more. 
• The overall hospital mortality rate was 28.6% but 38.4% in those 85 years or 
older. 
• The average length of stay and costs were 19.6 days and $22100. 
• If these numbers are extrapolated for the entire US, and adjusted for age and 
gender, it results in a yearly incidence of 3.0 cases per 1000 population with a 
total number of 751000 cases per year in the US, 215000 deaths and costs of 
$16.7 billion, thereof $8.7 billion (52.3%) for patients 65 and older and $5.1 
billion (30.8%) for those 75 and older. 
11 
• The study estimated an annual 1.5% increase of cases because of the 
demographic change in population. 
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1.2 Macrophages 
1.2.1 Function and derivation of macrophages 
The mononuclear phagocyte system is a subgroup of leukocytes, derived from bone 
marrow (Geissmann, 2010) (Murray & Wynn, 2011). Macrophages circulate in the 
blood as monocytes and within a few days they populate the tissue where they 
become macrophages.  
Monocytes are less specialized cells. Under inflammatory stimuli they are able to 
migrate into tissue, and to differentiate into macrophages or other cells. But they fulfill 
some effector functions themselves, too.  
Macrophages are phagocytic cells in the tissue, able to recognize pathogens and 
induce inflammation by the production of cytokines. 
1.2.2 Kupffer cells 
Kupffer cells (KC) represent 20% of all non-parenchymal cells in the liver and are the 
largest population of macrophages in the body (Racanelli & Rehermann, 2006). They are 
located predominantly in the periportal area of the sinusoidal vascular space. With 
their localization they can get into close contact with passing blood lymphocytes. 
Also they can pass between the liver sinusoidal endothelial cells into the space of 
Dissé where they interact with hepatocytes. 
Kupffer cells have an important regulatory role in the local immune system of the liver. 
For example they are involved in the presentation of antigens and the development of 
tolerance to antigens in the portal vein, the initiation of immune responses to 
infections, and they are in a close cytokine-mediated interaction with their 
neighboring cells. 
The release of cytokines – TNFα among them – by macrophages and especially 
Kupffer cells after stimulation with LPS is a topic of research since many years. The 
fact that LPS finally leads to a release of TNFα is widely accepted and known for a 
long time (Lin, 2005) (Decker, 1990).  
1.2.2.1 Role of Kupffer cells in sepsis 
Due to their function, their localization in the liver and their high number, Kupffer cells 
are thought to be an important player in bacterial infection and sepsis (Kono , 2006) 
(Gregory, 2002) (Seki, 2000). However, their exact role in this complex pathology is not 
yet clear. 
1.2.3 Purinergic receptor expression by macrophages 
Macrophages express various purinergic receptors, as virtually every circulating cell is 
responsive to nucleotides (Di Virgilio, Nucleotide receptors: an emerging family of 
regulatory molecules in blood cells, 2001). The specific subtypes expressed are not yet 
entirely cleared, but some are known: 
Murine macrophage lines express P2Y receptors (Di Virgilio, Nucleotide receptors: an 
emerging family of regulatory molecules in blood cells, 2001). RAW 264.7 macrophages 
express P2Y and a P2X7-like subtype. U-937 macrophages express P2Y2, P2Y4 and 
P2Y6 receptors. Human macrophages express P2X7.  
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There is little data about P2 receptor expressions by Kupffer cells (Beldi, 2008). On rat 
liver Kupffer cells P2X4 and P2X6 have been demonstrated (Xiang, 2006). There is no 
current literature about P2Y receptor expression in Kupffer cells. 
Kupffer cells are known to express Toll like receptors, TLR 4 among them (Chen Y. , 
2011) 
  
14 
1.3 Thrombocytes/platelets 
1.3.1 Formation of thrombocytes/platelets 
Thrombocytes, or platelets, originate from megakaryocytes (Beaulieu, 2010). 
Megakaryocytes are found in bone marrow. Upon stimulation, megakaryocytes 
adhere to the endothelium of the bone marrow and release pro-platelets into 
circulation. These undergo further maturation into platelets. 
1.3.2 Properties of platelets 
Platelets are mainly known for their hemostatic properties (Kumar, 2007). They are 
known to carry ADP and ATP in their dense bodies, which are released upon 
activation and contribute to and boost platelet adhesion and clot formation (Oury, 
2002).  
Based on these findings, we hypothesized, that platelets could be relevant for ATP 
release in a context of inflammation and thereby mediate inflammatory processes, for 
example in settings such as bacteremia or bacterial sepsis. If this were the case, the 
nucleotide secretion of platelets would not only have autocrine, but also paracrine 
and maybe even endocrine effects. 
1.3.3 Effect of nucleotides on platelets 
Platelets are activated by Nucleotides, i.e. ATP and ADP, via three P2 receptors. 
(Hechler, The P2 Receptors in Platelet Function, 2005) By P2X1, a ligand-gated cation 
channel activated by ATP, and by P2Y1 and P2Y12, two G-protein-coupled ADP 
receptors (Hechler, P2 receptors and platelet function, 2011). All of these receptors seem 
to play substantial roles in platelet activation, but P2Y12 appearing to be particularly 
important in the function of ADP as a cofactor in platelet activation.  
The importance of P2Y12 in platelet aggregation is underlined by the wide clinical use 
of its antagonist clopidogrel and further developments in cardiovascular diseases 
such as acute coronary syndrome. (Cayla, 2012) 
It has been shown, that ATP contributes to platelet activation via P2X1 receptor, 
when platelets are stimulated with only low concentrations of collagen (Oury, 2002). 
But if platelets are exposed to higher collagen concentrations, they are not dependent 
on this activation pathway anymore.  
1.3.4 Effect of LPS on platelets 
Furthermore, it has been demonstrated, that LPS can activate platelets together with 
subthreshold levels of thrombin or collagen and leads to ATP release of platelets 
(Zhang G. , 2009). But the activation of platelets via LPS is much weaker than by 
normal platelet agonists, such as collagen or thrombin. LPS alone does not activate 
platelets.  
1.3.5 Receptor expressions 
In primary clot formation of platelets, the GPIb complex (binding to von Willebrand 
factor) and platelet integrins such as α2β1 αIIβ3 play central roles (Clemetson, 2012). In 
the secondary activation of platelets, involved receptors include the P2 receptors 
P2X1, P2Y1, and P2Y12, the thrombin receptors PAR1 and PAR4, and the 
thromboxane receptor for TXA2 are particularly important. 
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Platelets further express TLR-1-9 and may therefore be activated by pathogen 
associated molecular pattern (Semple, 2011). Besides these, they express many other 
receptors and molecules with effects on the immune system, such as CD40 and 
CD154 (also known as CD40L), important molecules in promoting interactions 
between lymphocytes and antigen-presenting cells, and all the components of the 
LPS receptor signaling complex (including TLR4, CD14, MD2) (Semple, 2011), and 
others. . 
1.3.6 Role of platelets in inflammation and infection 
Within the last years a lot of evidence was found, that platelets interact with the 
immune system in the context of infections. For instance they can play a role in early 
immune surveillance, and they can localize and aggregate around bacteria and 
promote clearance, and thereby interact with immune responses (Beaulieu, 2010). 
LPS, which is an important factor in bacterial infections, has also been shown to have 
diverse effects on platelets such as increasing effects on platelet production, on 
circulating platelet numbers, and on platelet activation. 
The connecting element between platelets and the immune system could be TLR2 
and TLR4 receptors that are expressed on platelets (Beaulieu, 2010).  
We think, that another connecting element between platelets and the immune system 
could be the release of ATP by platelets. Thereby platelets would activate purinergic 
receptors on other cells, such as macrophages or other immune cells. If these signals 
were strong enough to activate or at least modulate immune reactions, it could be an 
important link between platelets and the immune system. 
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1.4 Endotoxin/lipopolysaccharides signaling 
Endotoxin is the lipopolysaccharide (LPS) of the outer membrane of Gram-negative 
bacteria. It consists of the biologically active component lipid A, and the two carrier 
parts named core and O antigen (Barbieri, 2007). 
1.4.1  Innate immune responses to danger signals: pathogen-associated 
molecular patterns (PAMPs) and pattern-recognition receptors (PRRs) 
Anything that causes tissue stress or damage is viewed as a “danger” by the immune 
system (Matzinger, 2002). Molecules associated with such stress or damage are called 
Danger-Associated Molecular Patterns (DAMPs), and are signaling such danger to the 
immune system. (Castelheim, 2009). These molecular patterns (DAMPS) are either 
produced by stressed or damaged tissues of the body (then they are called alarmins) 
or they are exogenous molecules derived from microorganisms (in this case they are 
called PAMPs).  
The latter exogenous molecules have in common that they are both essential for the 
microorganism’s surviving and its infective potential. They are called pathogen-
associated molecular patterns (PAMPs). LPS therefore is a PAMP.  
In order to recognize and react to these DAMPs (PAMPs and alarmins), the innate 
immune system developed a series of pattern-recognition receptors (PRRs). Toll-like 
Receptors (TLRs, see below) are an important member of the PRR group. Among 
these, TLR-4 recognizes LPS.  
1.4.2 Toll-like receptor-4 
Toll-like receptors (TLRs) are a family of transmembrane receptor proteins (Castelheim, 
2009). They are important pattern-recognition receptors (PRRs) and interact with the 
innate immune system. There are 13 TLRs in mammals, and 10 in human. With their 
recognition of danger signals, TLRs regulate the expression of various inflammatory 
cytokines. The precise composition of the secreted cytokine set depends on ligand 
specificity to the different receptors, the receptor expression patterns on the cell 
surface, and the downstream signaling pathways.  
TLR-4 is the classic and first example of a TLR described. It has been established to 
be the receptor of LPS, but also recognizes other molecules, structurally both similar 
and different to LPS. Even if TLR-4 is called to be “the” LPS receptor, it is not the only 
molecule involved in LPS signaling. 
1.4.2.1 Signaling pathways of TLR-4. 
TLR-4 forms a complex with myeloid differentiation-2 (MD-2) on the cell surface 
(Akashi-Takamura , 2008). MD-2 is a soluble protein associated to TLR-4. MD-2 seems 
to be the LPS recognition molecule while TLR-4 is responsible for the signaling; 
together they serve as the main LPS-binding component. 
LPS first binds to LPS-binding protein (LBP). LBP is an acute-phase protein, 
produced in the liver and circulating in the blood (Pålsson-McDermott & O'Neill, 2004) 
(Kawai, 2010) (Akira , 2006) (Castelheim, 2009). LBP delivers LPS to either soluble or 
membrane bound CD14. CD14 binds LPS and transfers the LPS-LBP complex to the 
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TLR-4-MD-2 complex. There is a soluble CD14 (sCD14) and a membrane bound 
(mCD14) form, which can both be involved in LPS signaling. 
Hence the first complex, which initiates the TLR-4 signaling, consists of LPS, LBP, 
CD14, MD-2, and TLR-4. Multiple TLR-4 then oligomerize for the further signal 
transduction. The specific structure of LPS, changing with the bacterial species, is 
essential for the cluster of TLR oligomerization and therefore also the resulting 
secondary messaging and inflammatory response. 
The cytoplasmic signaling domain of Toll-like receptors is homologous to that of the 
Interleukin-1 receptor (IL-1R) (Castelheim, 2009) (Akira , 2006). It is named Toll/IL-1R 
domain (TIR domain). Different TIR domain-associated molecules mediate the further 
signaling. Different TLRs activate different sets of TIR domain-associated molecules 
and thereby trigger different cellular responses (Kawai, 2010) (Akira , 2006). MyD88, 
TIRAP (Mal), TRIF, and TRAM are such associated molecules. Two main ways of TLR-
4 mediated intracellular response are known: an early MyD88-dependant, and a 
delayed TRIF-dependent response. TLR signaling pathways can be largely classified 
as either MyD88-dependent pathways, which drive the induction of inflammatory 
cytokines, or TRIF-dependent pathways, which are responsible for the induction of 
type I interferon as well as inflammatory cytokines (Kawai, 2010) [sic] (Akira , 2006). 
TLR-4 is the only TLR using both signaling pathways. (Figure 1) 
MyD88 dependent pathway  
TIRAP (Mal = MyD88 adaptor-like protein) (toll-interleukin 1 receptor domain 
containing adaptor protein) recruits MyD88 (Myeloid differentiation factor 88) to TLR-
4. (Kawai, 2010) (Akira , 2006). MyD88 then recruits different IL-1 receptor–associated 
kinases (IRAKs), which are required for the activation of NF-κB. Briefly, by interaction 
with a series of regulatory proteins such as TRAF6, TAK1, NEMO, and others, finally 
this cascade leads to activation of MAPK kinase, and degradation of IκB and thereby 
activation of NF-κB. NF-κB in its inactive form is bound to inhibitor of NF-κB (IκB) 
and regularly present in the cytoplasm. Phosphorylation of IκB by IκB kinase leads 
to a release of NF-κB, which then translocates into the nucleus and acts as a 
transcription factor (Pålsson-McDermott & O'Neill, 2004). MAPK kinase, NF-κB, and 
other factors activated by this pathway lead to production of proinflammatory 
cytokines. 
TRIF dependent pathway 
TRAM (TRIF-related adapter molecule) recruits TRIF (TIR-domain-containing adapter-
inducing interferon-β) to TLR-4 (Kawai, 2010) (Akira , 2006). TRIF also recruits TRAF6 
and via TAK1 and other proteins it leads to activation of NF-κB. Additionally TRIF 
recruits TRAF3 and a signaling complex involving TBK1, IKKi, and others. The 
activation of these proteins finally leads to IRF3 activation and interferon-β 
transcription. 
Interestingly, various proteins, e.g. TRAF3 are involved in the regulation of both the 
MyD88 dependent and the TRIF dependent pathways with oppositional effects. 
Thereby they may have essential roles in balancing the inflammatory stimulations 
(Kawai, 2010). 
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Figure 1: Simplified diagram of TLR-4 activation; Abbreviations: LPS – Lipopolysaccharides, LBP – 
LPS-binding protein; (m)CD14 – (membrane bound) Cluster of Differentiation 14; TLR-4 – Toll-like 
Receptor 4; TIR-Domain – Intracellular Toll/IL-1R domain; TIRAP(Mal) – Toll-Interleukin 1 Receptor 
Domain containing Adaptor Protein ( MyD88 adaptor-like protein) ; MyD88 – Myeloid differentiation 
factor 88; TRAM – TRIF-related adapter molecule; TRIF – TIR-domain-containing adapter-inducing 
interferon-β; IRAKs – IL-1 Receptor–Associated Kinases; NF-κB – Nuclear Factor kappa-light-chain-
enhancer of activated B cells; IκB – Inhibitor of NF-κB 
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1.5 Purinergic/nucleotide signaling 
Purinergic signaling consists of purines (i.e. primarily adenine), the purine nucleoside 
adenosine, purinergic nucleotides (i.e. mainly ATP and ADP), and pyrimidinergic 
nucleotides (i.e. manly UTP), their release into the extracellular space, their 
modulation by enzymes, and the stimulation of purinergic receptors (Burnstock, 
Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future , 2012) 
(Graubardt, 2012). Purinergic signaling was initially discovered as a novel 
neurotransmitting pathway, but since then many other effects in various cell types 
have been discovered. Purinergic signaling is involved in both short-term and long-
term signaling with a wide range of different effects within the organism. 
1.5.1 Purines/nucleotides 
Nucleotides consist of a purine- or pyrimidine base, a ribose (or deoxyribose 
respectively), and a phosphoric acid group (Löffler, Purin- und Pyrimidinstoffwechsel, 
2005). The most important purine in purinergic signaling is adenosine (Bours, 2006) 
(Graubardt, 2012). The most important nucleotides are adenosine 5’-triphosphate 
(ATP), adenosine 5’-diphosphate (ADP), and uridine 5’-triphosphate.   
Classically, ATP is known as an energy-carrier in cell metabolism (Löffler, Chemische 
Grundlagen des Stoffwechsels, 2005) but it has also been established as a signaling 
molecule, first in neuronal tissue, and later in non-neuronal cells, too (Burnstock, Purine 
and pyrimidine receptors, 2007). 
Intracellular ATP in epithelia is under basal conditions present in concentrations of 3-8 
mM (Eltzschig, Sitkovsky, & Robson, 2012) (Fitz, 2007), while its concentration is much 
lower in the extracellular plasma (400-700nM) (Bours, 2006) (Graubardt, 2012).  
1.5.2 Nucleotide release 
Different conditions such as cell death or inflammatory states and different pathways 
of nucleotide release are known (Eltzschig, Sitkovsky, & Robson, 2012). Necrosis and 
apoptosis lead to an uncontrolled ATP egress from intracellular stores, and a 
controlled ATP release through pannexin hemichannels, respectively. Activated 
immune and other cells release ATP through connexin hemichannels, and platelets 
release ADP from intracellular granules. Thereby released nucleotides can act as 
chemotactic signaling molecules. 
For a half-maximal activation of purinergic receptors, ATP is typically required in 
concentrations of 3-500 nM (Fitz, 2007). Nucleotide signaling therefore does not lead 
to alterations in the intracellular energy stores.  
1.5.3 Extracellular metabolism of nucleotides 
Due to various extracellular nucleotidases and other hydrolytic effects, ATP outside 
the cell has a very short half-life in the range of seconds (Fitz, 2007) (Bours, 2006) 
(Graubardt, 2012). The extracellular hydrolysis cascade leads to a sequential 
degradation of nucleotides into their respective nucleosides and free phosphate 
(Zimmermann, 2000).  
There are four families of ectonucleotidases responsible for nucleotide hydrolysis 
(Zimmermann, 2000): E-NTPDase family (ecto-nucleoside triphosphate 
diphosphohydrolase family), E-NPP family (ectonucleotide 
pyrophophatase/phosphodiesterase family), Alkaline phosphatases, and Ecto-5’-
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nucleotidase. The ectonucleotidases are normally membrane-bound enzymes, but 
soluble variants of various ectonucleotidases exist through cleavage from their 
anchor. It is noteworthy, that ectonucleotidases generally have broad individual 
substrate specificities and can hydrolyze triphosphate, diphosphate, and 
monophosphate variants of different nucleotides with different preferences.  
NTPDase1, also named CD39, is a member of the E-NTPDase family. Ecto-5’-
nucleotidase is also named CD73.  
1.5.4 Purinergic receptors 
Two families of purinergic receptors are known, named the P1 and P2 receptors.  
1.5.4.1 P1 receptors  
P1 receptors are G protein-coupled receptors and are divided into four subtypes (A1, 
A2A, A2B, A3). P1 receptors bind extracellular Adenosine (Burnstock, Purine and 
pyrimidine receptors, 2007).  
1.5.4.2 P2 receptors 
P2 receptors have two subfamilies, P2X and P2Y (Burnstock, Purine and pyrimidine 
receptors, 2007).  
P2X receptors are ligand-gated ion channel receptors. Seven subtypes of P2X have 
been characterized (P2X1-7).  
P2Y receptors are G protein-coupled receptors. Depending on the subtype they are 
coupling to different G proteins with either a stimulating or an inhibiting effect, or even 
both. Eight human subtypes of have been identified so far and they are divided into 
two subgroups (P2Y1, P2Y2, P2Y4, P2Y6, P2Y11; and P2Y12, P2Y13, P2Y14).  
All P2X and P2Y receptors respond to extracellular ATP with different affinities, and 
some to other natural and synthetic nucleotides, too (Jacobsson, 2012) (Graubardt, 
2012). For some of the receptors, more specific agonists and antagonists have been 
found (Burnstock, Purinergic signalling: Its unpopular beginning, its acceptance and its 
exciting future , 2012) (IUPHAR, 2012): E.g. BzATP is agonist for P2X1, P2X3, P2X7, 
P2Y11; ATPγS is agonist for P2X2, P2X5, P2Y1, P2Y11, P2Y12, P2Y13; and suramin 
is antagonist for P2X2, P2X5, P2Y2, P2Y4, P2Y11. ADP is agonist for P2Y1, P2Y6, 
P2Y12, and P2Y13. UTP is agonist for P2Y2, P2Y4, P2Y6, and P2Y11. 
1.5.4.3 Expression and interactions of purinergic receptors 
Purinergic receptors are expressed on many cells throughout the body, both 
neuronal, and non-neuronal cells, such as immune cells (Bours, 2006). The specific 
expression patterns of purinergic receptors on immune cells vary between cell types 
and depend on inflammatory states. However most immune cells express both 
subtypes, i.e. P1 and P2 receptors. 
Monocytes and Macrophages express various P1 and P2 receptor subtypes (Bours, 
2006). Specific expression of the P2 receptor may depend on maturation stage, and 
nature of cellular activation.  
In addition to different and mixed expression patterns, purincergic receptors show 
receptor dimerization (both homodimers and heterodimers) and receptor cross talk 
(Burnstock, Purine and pyrimidine receptors, 2007) (Jacobsson, 2012). Therefore they show 
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very complex physiological interactions both on the level of the receptors themselves, 
and within the downstream signaling.  
1.5.5 Effects of purinergic/nucleotide signaling on the immune system and 
repair mechanisms 
It is widely recognized that purinergic signaling is involved in many neuronal and non-
neuronal mechanisms (Burnstock, Purine and pyrimidine receptors, 2007).  
Bours (Bours, 2006) concludes, that because of these multiple observation, there is 
overwhelming evidence that extracellular nucleotides and purinergic receptors play a 
major role in immunity and inflammation. However, the role of extracellular 
nucleotides is extremely complex and interdependent and is not yet fully understood 
(Bours, 2006), (Graubardt, 2012). 
Adenosine and purine nucleotides often act in a reciprocal way, and therefore the 
balance and metabolism between Adenosine and purine nucleotides (which can be 
degraded into Adenosine) are an especially important factor in the effect of purinergic 
signaling (Eltzschig, Sitkovsky, & Robson, 2012). 
Furthermore, it has been shown, that purinergic signaling (i.e. ATP and Adenosine) is 
a key mediator in various disease states of the liver and other organs, such as in liver 
repair after injury or in hypoxic-reperfusion injuries as they occur during liver 
transplantation (Vaughn, Robson, & Burnstock, 2012) (Beldi, 2008) (Gonzales, 2010). 
In vivo, ATP decreased the circulating concentration of TNF and IL-6 after trauma-
hemorrhage and resuscitation, a condition, which normally increases these cytokines 
(Wang P. , 1992). 
In the following explanations I am focusing on the immune system and 
Monocytes/Macrophages. 
1.5.6 Effects of purinergic/nucleotide signaling on monocytes/macrophages 
Many factors affect purinergic signaling, such as type and concentration of the 
extracellular nucleotide, extracellular metabolism of the nucleotides through 
ectonucleoside kinases, and receptors expressed on the different cells. 
Monocytes express P2Y1,2,4,6,11,12,13, and P2X1,4,5,7 receptors [sic (Bours, 2006)] 
(Hickmann, 1994) (Falzoni, 1995) (Clifford, 1997) . (Martin, 1997) (Buell, 1998) (Humphreys, 
1998) (Jin, 1998) (Koziak, 1999) (Adrian, 2000) (Gu, 2000) (Chessel, 2001) (Mehta, 2001) 
(Moore, 2001) (Warny, 2001) (Aga, 2002) (Into, 2002) (Zhang F. L., 2002) (Derks, 2004) 
(Sluyter, 2004) (Wang L. , 2004) (Kaufmann, 2005).  
Macrophages express the same receptor subtypes except for P2Y13 [sic (Bours, 
2006)] (Hickmann, 1994) (Falzoni, 1995) (Martin, 1997) (Schmid-Antomarchi, 1997) (Buell, 
1998) (Adrian, 2000) (Chen B.-C. , 2000) (Moore, 2001) (Stober, 2001) (Adinolfi, 2002) 
(Eschke, 2002) (Bowler, 2003) (Hanley, 2004) (Coutinho-Silva, 2005).  
Monocytes/Macrophages exhibit CD39 as well as CD73 activity, and are capable of 
releasing both ATP and Adenosine upon activation, rendering them susceptible to 
autocrine and paracrine purinergic regulation by extracellular ATP and Adenosine [sic 
(Bours, 2006)]. 
Extracellular nucleotides have been described to have various effects on 
monocytes/macrophages and may even affect their inflammatory state (Bours, 2006). 
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The specific effects depend on many factors such as the nucleotide itself, purinergic 
receptor expression, nucleotide concentration, and the downstream activation 
pathway of the cells. Possible effects appear to be for example: a contribution to the 
adhesion of inflammatory monocytes to vascular endothelium (Ventura, 1995) (von 
Albertini, 1998) (Goepfert, CD39 modulates endothelial cell activation and apoptosis., 2000); 
recruitment and chemotaxis of monocytes/macrophages (McCloskey, 1999) (Goepfert, 
Disordered cellular migration and angiogenesis in cd39-null mice., 2001) (Honda, 2001); both 
up- and downregulation of production and release of cytokines (such as e.g. TNFα, 
IL-6) (Tonetti, 1995) and other inflammatory mediators; bi-directional modulation of 
phagocytosis; and apoptotic as well as necrotic cell death (Bours, 2006).  
Even though many effects have been observed, the exact mechanisms seem not yet 
to be fully understood and foreseeable.  
1.5.7 Effects of extracellular nucleotides on the phagocytic properties of 
macrophages 
Marques-da-Silva (Marques-da-Silva, 2011) could produce a significantly increased 
phagocytosis of latex beads by murine peritoneal macrophages when they were pre-
treated with ATP, ADP or UDP. Furthermore he could abolish these effects with pre-
treatments with various P2-receptor antagonists. Based on these and other 
experiments P2-receptors seem to be involved in the modulation of phagocytosis. 
On the other hand Elliott (Elliott, 2009) concentrated his work on the recruitment of 
macrophages towards apoptotic cells and could also show an effect of nucleotides. 
In two different in vivo models he demonstrated a more efficient recruitment of 
macrophages due to the presence of ATP and UTP. This effect could be abolished by 
depletion of nucleotides and decreased in P2Y2 -/- mice. Because of these results 
ATP and UTP were identified as find-me signals released by apoptotic cells and 
P2Y2-receptors on monocytes and macrophages as a critical sensor of the find-me 
signal. 
1.5.8 Effects of extracellular nucleotides on platelets 
The effects of extracellular nucleotides are established in the clotting properties of 
platelets and were described above in this work. The broad clinical implementation of 
this knowledge is the use of clopidogrel as an anticoagulant drug in coronary heart 
disease. 
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1.6 Experimental approach  
To investigate the role of extracellular nucleotides in the context of sepsis, we 
focused on primary and cultured monocytes/macrophages in vitro, which were 
exposed to lipopolysaccharides. In these models we administered different 
extracellular nucleotides to observe its effect on cytokine expression and 
phagocytosis of macrophages. 
Furthermore we planned to expose human thrombocytes to extracellular 
lipopolysaccharides and measure their effect on the nucleotide release of platelets. 
1.6.1 A) Do extracellular nucleotides modulate cytokine secretion of primary 
murine Kupffer cells after stimulation with LPS? 
To evaluate effects of hepatic macrophages in vitro we used a model with primary 
Kupffer cells (KCs) from mice. Primary Kupffer cells are easily gained in a sufficient 
amount using specific experimental techniques. Kupffer cells represent a large and 
relevant subpopulation of all macrophages in the body – also regarding to their 
immunological functions with effects possibly on the entire organism. As a laboratory 
associated with visceral surgery we are especially interested in Kupffer cells because 
of their localization in the liver. Being inflammatory cells Kupffer cells may be involved 
in regeneration processes, e.g. after liver resection, liver transplantation, hypoxia-
reperfusion damages, and others (Beldi, 2008) (Seki, 2000).  
Using a model with primary murine Kupffer cells we wanted to show a dose 
dependent effect of extracellular nucleotides on the cytokine release of LPS-
stimulated Kupffer cells. Briefly, we stimulated Kupffer cells with lipopolysaccharides 
and administered nucleotides (ATP, ADP, ATPγS, UTP, Bz-ATP) and a known P2-
receptor antagonist (Suramin) in different concentrations, and measured TNFα-
release using an ELISA assay. The goal was, based on preliminary data and previous 
publications to show dose-dependent difference of TNFα-release under the 
administration of nucleotides and the modulation of this effect with the P2-receptor 
antagonist. 
1.6.2 B) Do (human) thrombocytes/platelets release ATP after stimulation 
and/or co-stimulation with LPS? 
To search for a possible systemic effect of ATP, we focused on platelets, because 
they are circulating in the blood when compared to Kupffer cells.  
This activation of platelets by LPS and its release of nucleotides may play a role in 
systemic or local inflammatory or immune responses. In our experimental approach 
we initially planned to combine the effect of LPS on nucleotide release by platelets 
and the effect of nucleotides on cytokine release by macrophages. 
As previously described, activated platelets release and sense extracellular ATP and – 
predominantly – ADP to produce a positive feedback loop for an efficient primary clot 
formation during hemostasis (Kumar, 2007) (Oury, 2002). Platelets have also been 
shown to release ATP and ADP in response to LPS (Zhang G. , 2009). 
Our initial idea was to reproduce this effect first in human and then in murine 
platelets. If we had a reliable ATP/ADP release by platelets we aimed to combine the 
two experiments in order to explore an interaction of platelets and KC in response to 
LPS. Therefore we planned to use the supernatant of the activated platelets to put in 
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the media of Kupffer cells. LPS should activate platelets and make them release 
ATP/ADP. The supernatant with these released nucleotides should then replace the 
added nucleotides in the first series of experiments, and therefore deplete the effect 
of LPS on cytokine release by Kupffer cells.  
Briefly, we wanted to explore if LPS-activated platelets reduce the cytokine release by 
LPS-activated Kupffer cells and thereby reduce inflammatory reactions. 
1.6.3 C) Do extracellular Nucleotides influence phagocytosis by cell culture 
macrophages? 
An effect of extracellular nucleotides on phagocytosis by macrophages has been 
shown (Marques-da-Silva, 2011), (Elliott, 2009).  
For our work, we adapted the protocol from one of the authors referred to (Marques-
da-Silva, 2011). Instead of primary peritoneal macrophages we used macrophages 
from murine (RAW 264.7) and human (U-937) cell lines. With these macrophages we 
aimed to reproduce an increase of phagocytosis of bio particles (instead of latex 
beads) in response to stimulation with extracellular nucleotides. Based on such data, 
the further plan was to search the responsible receptor pathways for this effect. For 
that purpose possible means could be the use of various specific agonists and 
antagonists (of P2 receptors), and e.g. short interfering RNAs to specifically knock 
down single receptors responsible for the effect. 
To measure phagocytosis under the effect of extracellular nucleotides we used 
fluorescein-labeled bio particles. We incubated macrophages from cell cultures 
together with marked bio particles and stimulated with different concentrations of 
nucleotides. After washing out and quenching of the remaining – not phagocytized – 
particles, only the intracellular particles were measured either with a plate reader or 
by flow cytometry. 
In this experiment we were expecting – as the referred authors described – an 
increase of phagocytosis by the administration of extracellular nucleotides. A higher 
number of phagocytized bio particles per cell should be detectable as a higher 
fluorescence in the concerned well in a plate reader, and as higher mean fluorescence 
intensity and a different distribution pattern in a dot plot graph in flow cytometry. 
Thereby we wanted to show an effect of extracellular nucleotides on both 
inflammatory/immunity effects of macrophages, i.e. cytokine release and 
phagocytosis. 
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2 A) Effect of extracellular nucleotides on cytokine release 
in primary murine Kupffer cells after stimulation with LPS 
2.1 Introduction (idea & goal) 
As I described above in more detail, the goal and hypothesis of this part was, to show 
an altered cytokine (i.e. TNFα) release by LPS-stimulated primary murine Kupffer cells 
upon stimulation with extracellular nucleotides (e.g. ATP, ATPγS, ADP, and others), 
using an ELISA-assay. 
2.2 Material & methods 
To harvest murine Kupffer cells we used a terminal in vivo digestion model with 
subsequent serial centrifugation steps including a double percoll gradient, based on a 
previously described method (Aldeguer, 2002). 
2.2.1 Animals 
Animals were housed in accordance with the guidelines from the Swiss Veterinary 
Office in the animal facility of the “Departement für Klinische Forschung” (DKF) in 
Bern. Mice had free access to standard mouse chow. We studied BL/6 strain wild-
type mice (DKF animal facility, Bern) and P2Y2-null mice (kindly provided by 
Wolfgang G. Junger [Beth Israel Deaconess Medical Center, HMS, Boston], originally 
provided for another project). 
All the experiments were terminal during the cell harvesting procedure causing death 
by blood loss. Death at the end was confirmed by producing large bilateral 
pneumothoraxes.  
Operative procedures were performed by – or under supervision of – Guido Beldi, 
Adrian Keogh, Markus Trochsler or René Fahrner. 
2.2.2 Narcotics 
As narcotics we used either a triple anesthesia for mice or ketamine anesthesia for 
mice. Triple anesthesia consists of Dormitor® (Medetomidine) 1mg/ml and 500µg/kg, 
Climasol® (Climazolam) 10mg/ml and 5mg/kg, Fentanyl 0.5mg/ml and 50 µg/kg. 
Ketamine was applied at 100-200 mg/kg. 
2.2.3 Buffers and reagents  
For the liver perfusions a Chelation buffer containing EGTA (ethylene glycol tetra 
acetic acid), and a collagenase Buffer was used. All the buffers were prepared in 
clean conditions and then filtered or autoclaved, any further handling was done in 
sterile conditions in a laboratory bench. All buffers were stored at 4°C. 
2.2.3.1 Chelation Buffer 
Chelation Buffer was composed of 1x Leffert’s Buffer (which was made by a 10 
dilution of 10x Leffert’s Buffer) with 0.5 mM EGTA (ethylene glycol tetra acetic acid) 
(which was achieved my adding 0.625 ml of a 0.2 M EGTA stock into a final volume of 
250 ml 1x Leffert’s Buffer). 
26 
2.2.3.2 Leffert’s Buffer 
10x Leffert’s Buffer is composed of 250 mM (59.7 g/l) HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid), 1.15 M (69.27 g) NaCl (sodium chloride), 50 mM (3.73 
g) KCl (potassium chloride), 10 mM (1.36 g) KH2PO4 (potassium dihydrogen 
phosphate), and was produced in 1 liter ion free water and calibrated to a pH of 7.4, 
and then filtered. 
2.2.3.3 Collagenase Buffer 
Collagenase Buffer was composed of 1x Leffert’s Buffer (which was made by a 10 
dilution of 10x Leffert’s Buffer) with 2 mM CaCL2 (Calcium chloride) (This was 
achieved by adding 0.5 ml of a 1 M CaCL2 stock into a final volume of 500 ml 1x 
Leffert’s Buffer.), and 100 mg/l Collagenase (Type IV, Sigma-Aldrich). Collagenase 
Buffer was produced in a bulk of 500 ml, filtered into 50 ml tubes, and stored at 
minus 20°C. 
2.2.3.4 Culture medium 
As culture medium we used RPMI-1640 (Roswell Park Memorial Institute 1640 
medium) GlutaMAX™, (GIBCO/Invitrogen #61870) with 10% FBS (Fetal Bovine 
Serum, Heat Inactivated) (GIBCO/invitrogen #10500) and 1% Penicillin/Streptomycin 
(GIBCO/invitrogen # 15140122). This medium I call RPMI/FBS. 
2.2.3.5 Percoll 
Percoll (GE Healthcare # 17-0891-01) is used for gradient centrifugations. Percoll 
itself is hypotonic. Isotonic “stock-percoll” is produced by the addition of 9 parts 
percoll to 1 part 10x HBSS (Hanks Basic Salt Solution, 10x concentrated cell culture 
medium) (GIBCO/Invitrogen #14065-049). We used a double percoll Gradient: 50% 
(2.5ml) / 20% (3ml) in a standard 15 ml tube. It was produced by putting 3ml of 20% 
percoll in a 15 ml tube and gently layering 2.5ml of 50% percoll below. 20% percoll 
consists of 2 parts stock-percoll and 8 parts RPMI/FBS. 50% percoll consists of 5 
parts stock-percoll and 5 parts RPMI/FBS.  
2.2.3.6 Nucleotides 
ATP (Adenosine 5’-triphosphate disodium salt hydrate): Sigma Aldrich #A26209; ADP 
(Adenosine 5’-diphosphate): Sigma Aldrich #A2754; ATPγS (Adenosin 5’-(gamma-
thio)-triphospate): Jena Bio Science #NU-406; BzATP (2'(3')-O-(4-
Benzoylbenzoyl)adenosine-5'-triphosphate): Tocris Bioscience #3312; UTP (Uridine 
5′-triphosphate): Sigma Aldrich #U6750 
2.2.3.7 LPS 
Lipopolysaccharides from Salmonella enterica serotype abortus equi Sigma Aldrich 
#L6636 
2.2.4 Isolation of murine liver Kupffer cells 
Kupffer cells were isolated using an adapted previously described protocol (Aldeguer, 
2002). 
Bl/6 mice, usually 4 at the time, were put into narcosis with intraperitoneal injection of 
a Triple-Anesthesia or Ketamine (mixture and doses see above). Once the mice were 
in deep narcosis – confirmed by lack of muscle contraction after a potential painful 
27 
stimulus in the tail or lower extremities – a large transverse laparotomy was 
performed to get access to the liver and the inferior caval vein. The operations were 
performed using a binocular microscope. 
The inferior caval vein was punctured with a 22G sized standard infusion cannula and 
the portal vein was cut. With this installation and a roller pump perfusing the cannula 
at a speed of 1.72 ml/min, a retrograde perfusion of the liver could be achieved, 
which was controlled visually. Outflow of clear buffer fluid out of the cut portal vein, 
and brightening of the liver within a few minutes demonstrated good perfusion of the 
liver. 
The liver was perfused first with Chelation Buffer for 9 minutes, followed by the actual 
congestion with Collagenase Buffer for 13-18 minutes. The exact end point of liver 
congestion could be visually determined under the microscope, when the liver tissue 
within the capsule started to lose its structure. The congestion was performed under 
a warmth lamp, and with warmed buffers and pump to have an estimated in situ 
temperature of approximately 37°C.  
After the perfusion, the livers were removed, collected and pooled together in a cell 
culture dish with some RPMI/FBS-Medium inside. 
All the following steps were done in sterile conditions under the laboratory hood. 
The livers were cut into small pieces. Gentle shaking released the cells from the 
capsule. Then we filtered the cells through a polyamide mesh with 60 µm mesh 
opening (Sefar AG MEDIFAB® #03-60/42) into 50 ml tubes. The tubes were filled up 
with RPMI/FBS-Medium. 
In a first centrifugation step with 50g for 15 minutes the hepatocytes were pelleted 
while Kupffer cells remained in the supernatant. Secondly the supernatant containing 
Kupffer cells was centrifuged with 500g for minutes. This pellet was then 
resuspended in RPMI/FBS-Medium and layered on a double percoll gradient 
(50%/20%). 
In this double percoll gradient, a density centrifugation was performed with 800g for 
15 minutes. After the density centrifugation the interface between the 20% and 50% 
percoll layers– where the Kupffer cells are – was taken out with a sterile Pasteur 
pipette, and washed once with 500g for 7 minutes. 
The newly pelleted Kupffer cells were resuspended and dispersed in about 36 wells of 
a 96 well cell culture plate and given 15 minutes to sink and adhere to the bottom. 
After another washing step in the plate Kupffer cells were incubated over night 
(Aldeguer, 2002). 
2.2.5 Experimental design 
To activate the Kupffer cells we stimulated for 6 hours with LPS in different 
concentrations (mostly 25ng/ml) and compared to culture medium as a control. 
Immediately before stimulation with LPS we administered agonists (ATP, ADP, ATPγ
S, UTP, and Bz-ATP) and antagonists (suramin) in various concentrations.  
All stimulating substances were added at the same time point. The substances were 
added in very small volumes with accordingly higher concentrations to achieve final 
concentrations as indicated in the detailed protocols. We then incubated the cells for 
6 hours at 37°C with 5% CO2 in otherwise normal air before using the supernatant for 
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the measurements of cytokines. We measured TNFα (or IL-6) concentrations in the 
supernatants using an ELISA assay. Experiments were mostly performed in 
triplicates, some experiments (or parts) in duplicates only, because of a low amount 
of cells available at a time. 
Cells were not counted or standardized between the experiments, concentration 
values therefore cannot allow a statement about the amount of cytokines released per 
cell. This also does not allow comparing absolute values between different 
experiments, and also statements about the amount of cytokine produced per cell 
cannot be taken. Also for this reason, experiments will be presented separately. 
In the later sections I am going to present the setup and the results of the 
experiments separately. Afterwards I am summarizing the results of all experiments 
and taking general conclusion.  
 
2.2.6 Measurement of cytokine release (TNFα and IL-6) 
At the end of the stimulation we removed the supernatants. The according cytokine 
concentrations were measured using a commercial ELISA assay kit (PeproTech: 
TNFα No 900-K54, IL-6 No 900-K50). 
2.2.7 Statistical analysis and graphs 
All calculations and statistical analysis were made with Microsoft Excel. To estimate 
statistical significance of the results, a two-sided student’s t-test, type 2, was 
performed without previously analyzing values for their statistically normal 
distribution. The result we regarded as a p-value. P-values below 0.05 were 
considered significant. P-values (simply named p) are noted compared to the positive 
control (i.e. condition with LPS but without nucleotides), or to the negative control (i.e. 
condition without any stimulation at all) to control the effect of LPS alone. 
The error bars in the graphs represent the standard deviations from the mean of the 
triplicates/duplicates of every sample. 
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2.3 Results of the individual experiments 
In this chapter I am presenting the experiments and hypotheses behind, following the 
line of argument. TNFα concentrations (in parenthesis standard deviations of 
triplicates/duplicates) are in pg/ml in the supernatant, but not absolutely comparable 
between experiments. TNFα concentrations in the supernatant are interpreted as 
TNFα release. The individual experiments are numbered for a better traceability and 
orientation of the writer. 
For the sake of completeness all experiments are mentioned here, including 
experiments with technical problems at the end. 
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2.3.1 Is TNFα release by Kupffer cells in response to LPS dose dependent? 
Hypothesis 
Extracellular LPS is associated with TNFα release by primary murine Kupffer cells in a 
dose dependent manner. 
Setup 
In one experiment (ch08-003) Kupffer cells were stimulated with 0 and 25 ng/ml LPS. 
In another experiment (ch08-002) Kupffer cells were stimulated with 25, 100, and 400 
ng/ml. Both experiments were performed with co-stimulations with 0, 25, 100, and 
400 µM ATP. 
Results 
LPS at 25 ng/ml compared to 0 ng/ml is associated with an approximately five-fold 
increase of TNFα in the supernatant, p <0.001 (figure 2). A further increase of LPS 
from 25 to 100 or 400 ng/ml did not alter the TNFα-concentrations significantly, 
independently of the stimulation with ATP (no figure shown). 
Conclusion 
We therefore concluded, that LPS is associated with TNFα release by primary murine 
Kupffer cells, but not in a dose dependent manner within the tested range. 
2.3.2 Does ATP impact on TNFα release? 
Hypothesis 
Extracellular ATP impacts on TNFα release by LPS-stimulated primary Kupffer cells in 
a dose dependent manner. 
Setup 
In three experiments (ch08-002, 003, 004), we stimulated Kupffer cells with 0, 25, 
100, and 400 µM ATP and 25 ng/ml LPS. In one of them (ch08-002) Kupffer cells were 
also stimulated with 100 and 400 ng/ml, in another (ch08-003), ATP was also added 
without stimulation with LPS. 
Results 
In all experiments ATP 25 µM was associated with a significant decrease of TNFα 
release compared to controls. In two of the experiments, the effect of ATP was 
throughout dose dependent, e.g. compared with 0 ng/ml LPS. Increasing 
concentrations of ATP during the stimulation were associated with lower 
concentrations of TNFα, down to basal levels at 100 and 400 µM ATP (p <0.001 
against positive control without ATP). Using 25 µM ATP TNFα decreased 50% (p = 
0.014 against positive control) (figure 2). 
Only in one experiment (ch0-002), at 400 µM ATP the TNFα release was higher again 
than at 25 and 100 µM ATP. This was the first experiment of the series.  
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Figure 2: ch08-003_1: The figure shows the effect of different concentrations of extracellular ATP on 
the TNFα release of Kupffer cells with and without stimulation of LPS. (The error bars show standard 
deviations. P-value for 25µM ATP 0.014, for 100, and 400µM ATP <0.001) 
Conclusion 
Extracellular ATP decreases TNF secretion by primary KC in a dose dependent 
manner.  
Non-physiological high concentrations of extracellular ATP (400uM) abrogate TNFα 
release of LPS stimulated Kupffer cells. 
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2.3.3 Which specific P2 receptor agonists and antagonists impact on TNFα 
release by Kupffer cells? 
Next we wanted to identify if the observed ATP effect is mediated via specific P2 
(ATP) receptors. We postulated P2 receptor signaling to be the key mediator of this 
effect.  
Therefore, we used various specific agonists and antagonists to various P2 receptors 
to narrow down the probable set of responsible P2 receptors. 
2.3.3.1 ATPγS  
ATPyS is a non-hydrolysable ATP analog. Therefore, this agonist can be used to 
exclude relevant effects of AMP or Adenosine. ATPγS is the main agonist for P2X2, 
P2X5, P2Y11 (Burnstock, Purinergic signalling: Its unpopular beginning, its acceptance and 
its exciting future , 2012), and agonist for P2Y1, P2Y12, and P2Y13 (IUPHAR, 2012). A 
similar effect of ATPγS compared to ATP would therefore suggest that one of these 
receptors mediate inhibition of TNF secretion by KC. 
Hypothesis 
ATPγS decreases TNFα release by LPS-stimulated primary Kupffer cells in a dose 
dependent manner. 
Setup 
We stimulated Kupffer cells with 0, 25, 100 and 400 µM ATPγS with 25 ng/ml LPS 
(Figure 3; ch08-004). In the same experiment, Kupffer cells were also stimulated with 
0, 25, 100, and 400 µM ATP and 25 ng/ml LPS. All conditions were in triplicate 
samples. 
Results 
Stimulation with LPS alone increased the TNFα concentration. A concentration of 
both 25 µM ATP and 25 µM ATPγS reduced TNFα by 50% (p <0.005 and <0.0002 
respectively, compared to positive controls without nucleotides). A further increase of 
the nucleotide dose decreased TNFα additionally (figure 3). 
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Figure 3: ch08-004_1 TNFα release by LPS-stimulated Kupffer cells, modulated by extracellular ATP 
and ATPγS. 
Conclusion 
ATPγS decreases TNFα release by LPS-stimulated primary Kupffer cells in a dose 
dependent manner. Based on these results we exclude major adenosine or AMP 
dependent effects.  
2.3.3.2 ADP 
ADP is an agonist for P2Y1, P2Y6, P2Y12, and P2Y13 (Burnstock, Purinergic signalling: 
Its unpopular beginning, its acceptance and its exciting future , 2012) (IUPHAR, 2012). A 
similar effect of ADP compared to ATP would therefore suggest an involvement of 
one of these receptors in the previously observed effects. 
Hypothesis 
ADP decreases TNFα release by LPS-stimulated primary Kupffer cells in a dose 
dependent manner. 
Setup 
In one experiment (ch08-005) we stimulated Kupffer cells with 0, 5, 25, 100, 400, and 
1000 µM ADP with 25 ng/ml LPS. All conditions were in triplicate samples. 
Results 
ADP decreased TNFα-release with increasing nucleotide concentrations. Due to a 
large standard deviation in the control samples, a p < 0.05 was only achieved in the 
comparison of 0 µM ADP to 1000 µM ADP (figure 4). 
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Figure 4 (ch05-008): TNFα release by LPS-stimulated Kupffer cells, modulated by extracellular ADP. 
Conclusion 
ADP may decrease TNF secretion by primary Kupffer cells in a dose dependent 
manner, but to achieve clear and consistent significance, further experiments are 
necessary. An involvement of ADP sensitive P2 receptors (i.e. P2Y12, P2Y13) seems 
possible, but may not be dominant in purinergic signaling in Kupffer cells. 
The results in this experiment are not significant enough to be definitely interpreted. 
That’s due to the wide standard deviations, which are probably because of technical 
problems. But the trend in this experiment shows a dose dependent decrease of 
TNFα release after stimulation with ADP. This makes further repetitive experiments 
promising. 
2.3.3.3 UTP 
UTP is an agonist for P2Y2, P2Y4, P2Y6, and P2Y11 (Burnstock, Purinergic signalling: 
Its unpopular beginning, its acceptance and its exciting future , 2012) (IUPHAR, 2012). A 
similar effect of UTP compared to ATP would therefore suggest an involvement of 
one of these receptors in the previously observed effects. 
Hypothesis 
UTP decreases TNFα release by LPS-stimulated primary Kupffer cells in a dose 
dependent manner. 
Setup 
Altogether we performed three experiments (ch08-003, 004, 005) with UTP. Within 
these experiments, taken together, all conditions were applied once; only 100µM UTP 
and the controls without UTP were performed twice and three times, respectively.  
We stimulated Kupffer cells with 0, 2.5, 5, 10, 25, 40, 100 (in two experiments), 400, 
and 1000 µM UTP and 25 ng/ml LPS. 
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Results 
Extracellular UTP is associated with a modest decrease of TNFα release in LPS 
stimulated Kupffer cells.  
In one experiment (ch08-003) a 50% decrease of TNFα was achieved with 100 µM 
UTP, p = 0.028. Lower UTP-concentrations showed dose dependent decreases, too, 
but were statistically not significant (p > 0.1) (figure 5). 
In another experiment (ch08-004), UTP at 10 and 40 µM also reduced TNFα net of 12, 
respectively 18 %, p < 0.05, and 100 µM UTP leaded to a further decrease p = 0.05 
(figure 6). 
In the third experiment (ch08-005), UTP showed a trend to a dose dependent 
decrease of TNFα with increasing nucleotide concentrations (400, and 1000 µM UTP). 
Because of wide standard deviations this result was not significant (figure 7). 
 
Figure 5: ch08-003_2 TNFα release by LPS-stimulated Kupffer cells, modulated by extracellular UTP. 
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Figure 6: ch08-004 TNFα release by LPS-stimulated Kupffer cells, modulated by extracellular UTP. 
 
 
Figure 7: ch08-005_1 TNFα release by LPS-stimulated Kupffer cells, modulated by extracellular UTP. 
Conclusion 
UTP may decrease TNF secretion by primary Kupffer cells in a dose dependent 
manner, but to achieve clear and consistent significance, further experiments are 
necessary. In repetitive and controlled experiments, the UTP concentrations needed 
for a certain effect on TNF release should be determined with smaller technical 
variations. Based on the presented results it is possible, that UTP sensitive P2 
receptors (i.e. P2Y2, P2Y4, P2Y6, P2Y11) are at least partly involved in purinergic 
signaling of Kupffer cells. UTP is only an agonist of P2Y receptors, but not of P2X 
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37 
receptors. Therefore it is also probable, that G-protein coupled signaling is a key 
mechanism of how extracellular nucleotides impact on TNF release. But with these 
results alone, an effect of P2X receptors cannot yet be excluded. 
2.3.3.4 BzATP 
BzATP is an agonist for P2X1, P2X3, P2X7, and P2Y11 (Burnstock, Purinergic signalling: 
Its unpopular beginning, its acceptance and its exciting future , 2012). A similar effect of 
BzATP compared to ATP would therefore suggest an involvement of one of these 
receptors in the observed effects. 
Hypothesis 
BzATP decreases TNFα release by LPS-stimulated primary Kupffer cells in a dose 
dependent manner. 
Setup 
In one experiment (ch08-006) we stimulated Kupffer cells with 0, 1, 10, and 100 µM 
BzATP with 25 ng/ml LPS. All conditions were in triplicate samples. 
Results 
Extracellular BzATP decreased secretion of TNFα by LPS activated KC. TNFα 
secretion was decreased with 1 µM BzATP around 30% (p = 0.0157), with 10 µM 
around 50% (p = 0.0076), and with 100 µM Bz-ATP around 75%, compared to the 
positive control (p = 0.00046) (figure 8). 
 
Figure 8: ch08-006_2 TNFα release by LPS-stimulated Kupffer cells, modulated by extracellular 
BzATP.  
Conclusion 
BzATP is associated with a strong decrease of TNFα release by LPS-stimulated 
primary Kupffer cells in a dose dependent manner. Based on these results we 
conclude that one of the BzATP sensitive receptors (i.e. P2X1, P2X3, P2X7, P2Y11) is 
probably involved in purinergic signaling in murine Kupffer cells.  
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2.3.3.5 Suramin 
Suramin is an antagonist for P2X2, P2X5, P2Y2, P2Y4, and P2Y11 (Burnstock, 
Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future , 2012). A 
partial or complete inhibition of the effect of extracellular ATP with Suramin would 
suggest, that the signaling of extracellular ATP is relevantly mediated by one of these 
receptors. 
Hypothesis 
Suramin – applied together with ATP – diminishes or even abolishes the effect of 
extracellular ATP and therefore leads to a dose-dependent increase of TNFα, 
compared to the ATP-suppressed TNFα-release.  
Setup 
Two experiments with Suramin were carried out (ch08-005, 006). In one experiment 
(ch08-005) Suramin was added at concentrations of 0, 10, 100, and 400 µM together 
with 25 ng/ml LPS. 30 minutes later a 100 µM ATP-concentration was administered. 
In the other experiment (ch08-006) Suramin was added at concentrations of 0, 1, and 
10 µM together with 25 ng/ml LPS. 30 minutes later a 100 µM ATP-concentration was 
administered.  
Additionally a control for Suramin in the same concentrations was made without 
administering ATP, to evaluate the effects of Suramin itself. Both experiments were 
carried out with triplicate samples in all conditions. 
Results 
In one experiment (ch08-005) with LPS and ATP stimulated Kupffer cells, 10 µM 
extracellular Suramin did not alter TNFα concentration. 100 µM Suramin increased 
TNFα threefold (p 0.01) (figure 9). With 400 µM Suramin we measured values of zero 
or close to zero in the ELISA-assay. They are not shown in the figure, because a 
technical problem is likely.  
In the other experiment (ch08-006) Suramin 1µM and 10 µM – without ATP – TNFα 
decreased 35-40%, p <0.05. When Suramin was added in the same concentrations 
together with 100 µM ATP, TNFα secretion, which has already shown a 78% 
decrease after stimulation with ATP, further decreased, p <0.001 and <0.00005 
(Figure 10). 
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Figure 9: ch08-005 TNFα release by LPS-stimulated Kupffer cells, modulated by extracellular ATP and 
Suramin.  
 
 
Figure 10: ch08-006_1 TNFα release by LPS-stimulated Kupffer cells, modulated by extracellular ATP 
and Suramin. 
Conclusion 
The results of these experiments were not conclusive. Suramin showed divergent 
effects at different concentrations. Suramin may therefore antagonize the purinergic 
signaling of Kupffer cells at higher concentrations, but further experiments are needed 
to verify these results and to determine the necessary concentration. 
Other groups have showed effects of suramin in relation with purinergic signaling: 
Marques-da-Silva et al (Marques-da-Silva, 2011) could abolish a response of 
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macrophages to UTP with suramin, measuring phagocytosis of latex beads. Yebdri et 
al (Yebdri, 2009) could show that 100µM suramin diminishes P2Y2 and P2Y6 receptor 
mediated IL-8 release of monocytes, which is responsible for TLR-2 mediated 
neutrophil migration.  
2.3.3.6 P2Y2 
P2Y2 -/- knock out mice lack P2Y2 receptor. If P2Y2 is the mainly responsible 
receptor for purinergic signaling of extracellular ATP in Kupffer cells, we expected an 
effect of extracellular ATP to lack on P2Y2 -/- knock out mice.  
Hypothesis 
ATP does not decrease TNFα release in LPS stimulated Kupffer cells from P2Y2 -/- 
knock out mice, or its effect is significantly lesser than in wild type mice. 
Setup 
For this experiment (ch09-022) only two mice were used, instead of normally four. 
Conditions were only in duplicate samples. Kupffer cells from P2Y2 -/- mice were 
stimulated with 0, 5, 25, 100 µM of ATP, UTP, and ADP respectively, and with 25 
ng/ml LPS. 
Results 
In P2Y2 -/- mice ATP TNFα decreased 20, 55, and 75% with 5, 25, and 100 µM ATP 
respectively (figure 11). P <0.05 only with 100 µM ATP. UTP and ADP didn’t have a 
significant effect on TNFα-release in Kupffer cells of P2Y2-/- knock out mice (not 
shown in the figure). 
 
Figure 11: ch09-022_1 TNFα release by LPS-stimulated Kupffer cells from P2Y2-/- knock out mice, 
modulated by extracellular ATP.  
Conclusion 
P2Y2 is not a single key receptor for ATP in purinergic signaling of Kupffer cells. 
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A 50% decrease of TNFα with the administration of 25 µM extracellular ATP is the 
same effect as presented in previous experiments. Therefore the knocking out of 
P2Y2 in Kupffer cells does not alter puringergic signaling. Either this may be because 
P2Y2 is not the responsible receptor or because it can be sufficiently bypassed by 
redundant signaling pathways with other receptors. However, in order to exclude a 
minor effect, these experiments need to be performed in parallel with wild type cells.  
2.3.3.7 CD39 
CD39 -/- knock out mice lack CD39 ectonucleotidase. If CD39 is relevantly cleaving 
extracellular ATP we expected stronger effects of extracellular ATP in CD39 -/- knock 
out mice. It is hard to predict whether this effect is more relevant at higher or lower 
concentrations of extracellular ATP. 
Hypothesis 
ATP at lower concentration leads to a more distinct dose dependent decrease of 
TNFα release in LPS stimulated Kupffer cells from CD39 -/- knock out mice than in 
wild type mice. 
Setup 
For this experiment (ch09-022) only one mouse was used, instead of normally four. 
Conditions were only in duplicate samples. Kupffer cells from CD39 -/- mice were 
stimulated with 0, 5, 25, 100 µM ATP and with 25 ng/ml LPS. 
Results 
In CD39 -/- Kupffer cells, ATP decreased TNFα in a dose dependent manner up to 25 
µM ATP. 100 µM ATP did not further decrease TNFα. From 810 (67) pg/ml without 
ATP, TNFα decreased 28, 50, and 49% with 5, 25, and 100 µM ATP respectively, p 
<0.05 (figure 12). 
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Figure 12: ch09-022_2 TNFα release by LPS-stimulated Kupffer cells from CD39-/- knock out mice, 
modulated by extracellular ATP. 
Conclusion 
CD39 ectonucleidase is probably not relevant in purinergic signaling of Kupffer cells. 
A 50% decrease of TNFα after stimulation with 25 µM ATP is equal to wild type cells. 
Therefore CD39 probably does not relevantly diminish extracellular ATP concentration 
in vitro regarding the effect of ATP on TNFα release. However, in order to exclude a 
minor effect, these experiments need to be performed in parallel with wild type cells. 
2.3.4 Interleukin-6 
In one series of experiments (ch08-003) we carried out ELISA assays for Interleukin-6 
(IL-6). In these experiments Kupffer cells were stimulated with 0, 25, 100, 400 µM ATP 
both without LPS and with 25 ng/ml LPS, and with 0, 5, 25, 100 µM UTP. All 
conditions were in triplicate samples. The ELISA assay for IL-6 showed no significant 
effect of extracellular ATP or UTP. 
2.3.5 Experiments with technical problems 
For the sake of completeness two experiments which were performed, but showed 
obvious technical problems are mentioned here.  
In the very first experiment (ch08-001) Kupffer cells were stimulated with 0, 25, and 
100 µM ATP, and with 25 µM UTP and all these conditions were stimulated with 25, 
100, and 400 ng/ml LPS. Because of a mistake in the ELISA development (none of 
the necessary Hydrogen peroxide was added to the ABTS Liquid substrate) no results 
could be generated. All conditions were reproduced in later experiments described 
above. 
In another experiment (ch09-022) Kupffer cells from two wild type mice were 
stimulated with 0, 5, 25, 100 µM of ATP, UTP, and ADP respectively, and with 25 
ng/ml LPS. This experiment was performed together with the two knock out 
experiments described above. In this experiment no detectable TNFα concentrations 
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could be measured in the ELISA assay, probably because the amount of cells isolated 
from the two mice was not large enough. 
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2.4 Summarized results 
Secretion of TNFα by LPS-stimulated Kupffer cells in response to different 
nucleotides, such as ATP (figure 2), ATPyS (figure 3), BzATP (figure 7), was measured 
in supernatant using ELISA. Our experiments show a decrease of TNFα in response 
to stimulation with nucleotides.  
In summary, the figures show that extracellular LPS stimulate release of TNFα in 
murine Kupffer cells and that extracellular nucleotides inhibit this effect in a dose 
dependent matter. 
In the tested range, i.e. from 25 to 400 ng/ml extracellular LPS, the effect of LPS was 
not dose-dependent; higher LPS concentrations did not lead to higher TNFα release 
(no figure shown). The effects of extracellular nucleotides were dose dependent; 
higher nucleotide concentrations were associated with a stronger decrease of TNFα 
release and even abolished the effect of LPS. 
In figure 3 we have shown that the effects of ATP and ATPyS only differ at higher 
concentrations. In figure 8 we have shown that the effect of BzATP is very similar to 
the effect of ATP. The effects of UTP and ADP at the same concentrations are lower 
compared to ATP, as described and shown in figures 5 -7.  
We could consistently and significantly reproduce both the effect of LPS resulting in 
higher, and the effect of nucleotides in lower TNFα concentrations in the supernatants 
of LPS-stimulated primary murine Kupffer cells. Especially ATP, ATPγS and BzATP 
showed very conclusive results. UTP (Figures 5-7) and ADP instead only showed 
tendencies towards a similar effect, but less effectively and less significantly.  
Especially we could show the same effects with the non-hydrolysable ATPγS  (figure 
3) and the P2-receptor agonist Bz-ATP  (figure 8), while an antagonizing effect of 
Suramin has not clearly been shown (figure 9 and 10). 
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3 B) ATP release of human platelets after stimulation and 
co-stimulation with LPS 
3.1 Introduction (idea & goal) 
As I described in the Background section, the goal of this series of experiments was, 
to reproduce a nucleotide release by platelets/thrombocytes upon (co-) stimulation 
with extracellular LPS. The idea then was, to combine this effect, with the first series 
of experiments: We planned to use the ATP released by stimulated platelets, to 
modulate TNFα release of stimulated Kupffer cells. 
3.2 Material & methods 
To isolate human platelets we tried two different methods, modified from various 
methods we found in the actual literature. The two main principles applied, starting 
from human full blood were the followings:  
On one hand we used a two-step serial centrifugation with different speeds and times 
to first get platelet-rich blood plasma, of which the platelets are then pelleted 
(Weissmüller, 2008). This concept was applied in variations using different buffers.  
On the other hand we used a Sepharose based approach in which we filtered 
platelet-rich plasma using a Sepharose gel (Alberio, 2000). 
We measured ATP/ADP release with an ATP Luminescence assay kit (Perkin Elmer, 
ATPlite, No. 6016943), which we used in a modified manner. 
3.3 Experiments with technical problems – results 
Even if we were using the same or only slightly varied protocols as used and 
published by other groups before, we were not able to reproduce consistent results 
regarding the nucleotide release of platelets. Neither was it possible to reproduce 
their results, nor to generate new effects. 
Generally we observed both very large variations within duplicates/triplicates of the 
same conditions in a single experiment (i.e. huge standard deviations), and different 
tendencies between multiple versions of the same experiments, too. 
Unfortunately we were not able to resolve our technical problems. 
The most (even if not very) consistent result was the unsurprising effect of collagen 
and thrombin on platelets. In these conditions we normally got an increased signal in 
our ATP assay. We could not show a consistent effect of LPS in a co-stimulation 
together with collagen or thrombin as others have showed it. This means we had 
neither a consistent positive nor negative effect nor a consistent missing effect of LPS 
on the ATP release of platelets. 
The expected increase of ATP-release by platelets after stimulation with LPS could 
not be produced. Other unexpected different effects of LPS could not be observed as 
well. 
Therefore these experiments are considered as unsuccessful and no data or graphs 
are shown and materials and methods are not described in more detail. Even though, 
multiple data exist showing ATP release by platelets. We therefore think it was a 
technical problem that leaded to the unsuccessfulness of the planned experiments.  
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3.4 Conclusion/discussion 
It is difficult to tell why the experiments didn’t work. Obviously platelets seem to be 
very fragile cells to isolate, with different isolation protocols in the literature for almost 
every publication. Even minor changes in the conditions, such as the temperature, or 
shear forces (maybe the ones when aspirated through the needle already enough) 
may activate the platelets and thereby falsify the results of the following experiments. 
The kinetics of platelet activation and nucleotide release seems to be very fast. 
Therefore it may be quite difficult to measure precisely and reliably, and only possible 
with adequate equipment used by other groups. Aggrego-luminometers for example 
can measure clot formation and nucleotide release of platelets simultaneously and in 
real-time, but we did not dispose of one.  
A more intensive search for a solution of the difficulties noted above with optimized 
technical infrastructure and protocols was unfortunately not within the range of our 
temporal and financial capacities. Further research in the future seems reasonable 
and promising, anyway, because others could already generate promising results. 
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4 C) Effect of extracellular Nucleotides on phagocytosis of 
fluorescein labeled inactivated E. coli bio particles by 
RAW 264.7 and U-937 cell culture macrophages. 
4.1 Introduction (idea & goal) 
As noted in the background-section the goal of these experiments was, to reproduce 
experiments performed by other groups showing that extracellular nucleotides 
increase the phagocytosis of macrophages, with our cell types. Various authors 
(Marques-da-Silva, 2011) (Elliott, 2009) could demonstrate an effect of extracellular 
macrophages on different aspects of the behavior of macrophages, such as 
phagocytosis and migration.  
After having consistently reproduced this effect, the next step would be to go for the 
search of the responsible receptor(s) and signaling pathway(s). 
This series of experiments consists of two experimental setups with different 
measurements. One was based on using a plate reader, which measures the 
fluorescence of cell culture wells. In these experiments, we used RAW 264.7 cell 
(described below). The other setup was based on flow cytometry measurement. For 
these experiments we mostly used U-937 cells (described below). 
4.2 Material & methods 
The following protocols are adapted from Anita Born and René Fahrner who did 
similar experiments in our laboratory, and from other authors cited above (Marques-da-
Silva, 2011). 
Because the different cell lines used needed different handling, I am separating this 
section in two blocks, one for each cell line. 
4.2.1 RAW 264.7 
The cell line RAW 264.7 (ATCC® Number TIB-71™) (Raschke, 1978) is derived from 
ascites monocytes/macrophages of mice with Abelson murine leukemia virus-
induced tumor (LGC Standards - ATCC). The cells were handled as described by ATCC 
(LGC Standards - ATCC). 
RAW 264.7 cells we used mainly for the phagocytosis assay with the plate reader 
(experiments No. ch11-001-006; 008-010), and once in an experiment using flow 
cytometry (ch11-007). 
4.2.1.1 Buffers, materials and reagents 
Bio Particles 
For phagocytosis we used killed fluorescently labeled Escherichia coli (K-12 strain) 
BioParticles® (bio particles, BP) with approximate Absorption/Emission maxima of 
494/518 nm (Molecular Probes/invitrogen # E-2861) that were prepared as described 
by the manufacturer.  
Media 
DMEM: Dulbecco's Modified Eagle Medium (DMEM), high glucose, GlutaMAX-I, 
pyruvate (GIBCO/Invitrogen # 31966); FBS: Fetal Bovine Serum (Heat Inactivated) 
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Origin: EU Approved (South American) (GIBCO/invitrogen #10500); PBS: Dulbecco's 
Phosphate-Buffered Saline; DPBS, no calcium, no magnesium; (GIBCO/invitrogen 
#14190); (P/S) Penicillin/Streptomycin (GIBCO/invitrogen #15140122). 
The culture media was used with or without – depending on the specific protocol –
10% FBS, and with 1% P/S. 
Nucleotides 
ATP (Adenosine 5’-triphosphate disodium salt hydrate): Sigma Aldrich #A26209 for 
the experiments with the plate reader and #A2383 for experiments with flow 
cytometry; ADP (Adenosine 5’-diphosphate): Sigma Aldrich #A2754; ATPγS (Adenosin 
5’-(gamma-thio)-triphospate): Jena Bio Science #NU-406; BzATP (2'(3')-O-(4-
Benzoylbenzoyl)adenosine-5'-triphosphate): Tocris Bioscience #3312; UTP (Uridine 
5′-triphosphate): Sigma Aldrich #U6750 
Other materials and instruments 
In addition we used the following products: Trypan Blue: 80mg in 40ml PBS for 0.2% 
w/v (Sigma #T6146); Trypsin-EDTA (GIBCO/invitrogen #15400-054), tissue cell culture 
plates of 96 wells (Sarstedt Cell+ # 83.1835.300) and tissue culture plates of 24 wells 
(Sarstedt # 1 83.1836) and 12 wells (nunc #150628); cell scraper (Sarstedt #83.1830); 
FACS-tube: 5ml round bottom Polystyrene tube, (Sarstedt #55.476.013 PS). 
Standard plate reading measurements were done with Infinite® M200 (Tecan).  
4.2.1.2 Preparation of the cells 
The entire handling of the cells was done in sterile conditions under a laboratory 
hood. All incubation and treatment steps were at 37°C and 5% CO2. 
The RAW 264.7 cells were plated in a sterile 96-well plate in a concentration of 
100’000 cells/50µL in each well and incubated over night. According to the specific 
protocol the incubation was with or without FBS.  
For the experiment with flow cytometry, larger wells and amounts of cells were used. 
4.2.1.3 Basic stimulation protocol 
The next day we pre-treated the cells with either nucleotides (dissolved in DMEM 
media) or control media (DMEM) in an additional 50µL/well. After the pre-treatment 
we added E. coli bio particles dissolved in 100µL DMEM in a concentration of 
approximately 10x106 particles/well (for 100 BP/cell, and adapted for specific 
protocols) and incubated again for different times. 
To end the stimulation/phagocytosis, and to quench the fluorescein on the remaining 
extracellular bio particles, the supernatant was removed and 100µL Trypan Blue 0.2% 
(in distilled water) was added for 2 minutes. The wells were then washed three times 
with Phosphate buffered saline (PBS), or until the wells were clear. 
As a visual control the cells with phagocytized bio particles could be viewed in a 
fluorescence microscope where it was clearly visible, that the fluorescent bio particles 
were not homogenously distributed in the wells, but only visible in small, roundish-
shaped areas, resembling the forms of cells (no photo documentation). 
For the experiment with flow cytometry, to the RAW 264.7 cells 500µL Trypsin/EDTA 
were added for 5 minutes at room temperature to release the cells from the wells. The 
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cells were then scraped and washed off the plate with PBS, transferred in a FACS 
tube, washed once and resuspended in PBS for flow cytometry. 
4.2.1.4 Measurement of phagocytosis by fluorescence, using a plate reader 
For a quantitative measurement of the engulfed particles we used the plate reader 
Tecan infinite M200 at 488/522nm (Excitation=Absorbance/Emission).  
All the results are in arbitrary light units. 
4.2.1.5 Statistical analysis and graphs 
All calculations and statistical analysis were made with Microsoft Excel. To estimate 
statistical significance of the results, a two-sided student’s t-test, type 2, was 
performed without previously analyzing values for their statistically normal 
distribution. The result we regarded as a p-value. P-values below 0.05 were 
considered significant.  
The error bars in the graphs represent the standard deviations from the 
tetraplicates/triplicates/duplicates of every sample. 
4.2.2 U-937 
The cell line U-937 (ATCC® Number CRL-1593.2™) derives from human histiocytic 
lymphoma monocytes (Sundström, 1976). It was handled as described by ATCC (LGC 
Standards - ATCC) and used for experiments with flow cytometry (experiments No. 
ch11-007; 011-018).  
4.2.2.1 Buffers, materials and reagents 
Bio particles, Nucleotides, and other reagents for U-937 cells were identical with the 
ones for RAW 264.7 cells.  
The media used was RPMI: Roswell Park Memorial Institute 1640 medium; RPMI-
1640, GlutaMAX™, (GIBCO/Invitrogen #61870). 
The culture media was used with or without – depending on the specific protocol –
10% FBS, and with 1% P/S. 
SORP LSRII™ (BD Bioscience) was used for flow cytometry measurements. 
4.2.2.2 Preparation of the cells 
The entire handling of the cells was done in sterile conditions under a laboratory 
hood. All incubation and treatment steps were at 37°C and 5% CO2. 
The U-937 cells were plated in a sterile 96-well plate in a concentration of 100’000 
cells/100µL and incubated over night. According to the specific protocol the 
incubation was with or without FBS.  
4.2.2.3 Basic stimulation protocol 
The next day we pre-treated the cells with either nucleotides (dissolved in RPMI) or 
control media for 30 min. Then we stimulated them with bio particles in 
concentrations according to the specific protocol for 2 hours (other times according 
to specific protocols).  
To end the stimulation/phagocytosis, cells were put on ice (Marques-da-Silva, 2011).  
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The U-937 cells were transferred into FACS tubes and centrifuged (2000rpm ≅ 800g 
for 7 minutes at 4°C).  
To quench the fluorescein on the remaining extracellular bio particles, 500µL Trypan 
blue 0.2% were added for 2 minutes. The tubes respectively, were then washed three 
times, or until the wells were clear with Phosphate buffered saline (PBS). The non-
adherent U-937 cells needed to be centrifuged (800g for 7 min) in every washing step. 
The U-937 cells were directly resuspended in PBS for flow cytometry after the last 
washing step. 
4.2.2.4 Measurement of phagocytosis by fluorescence, using flow cytometry 
Flow cytometry was performed in the SORP LSRII machine with the 
Absorption/Emission properties set on the ones for Fluorescein isothiocyanate (FITC). 
As a positive control in the first experiments we used highly diluted bio particles (1 to 
1000 times diluted compared to the concentration during the stimulation of the cells). 
4.2.2.5 Statistical analysis and graphs 
We determined mean fluorescence of FITC positive cells. FITC positive cells were 
defined as cells with higher fluorescence activity than approximately 95% of the cells 
in the negative control. 
The mean values from the experiments and dotplot graphs were generated with 
FlowJo software and prepared for Microsoft Excel. Statistical analyses were 
performed with Microsoft Excel equally to the experiments with the plate reader. 
Dotplot graphs did not show any visual differences and are therefore not added to 
this work. 
4.3 Experimental design 
Macrophages were pre-stimulated with different concentrations of various 
nucleotides (ATP, ADP, ATPγS) for 30 minutes or the nucleotides were added 
simultaneously with the bio particles. Then bio particles were added in different 
concentrations for different durations. After the stimulation period, the cells were put 
on ice to stop the phagocytosis, and the fluorescence of the remained extracellular 
bio particles was quenched with trypan blue. The cells were then washed and 
prepared for the particular measuring method used, as previously described.  
The amount of phagocytosis by the macrophages was then determined by the 
fluorescence in the well in the plate reader, or by the mean fluorescence of the cells 
within the population of viable macrophages in flow cytometry. 
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4.4 RAW 264.7 – results of individual experiments 
4.4.1 RAW 264.7 macrophages phagocyte fluorescence marked bio particles 
independently from serum starvation 
Hypothesis 
Macrophages phagocyte bio particles, which can be detected by an increase of 
fluorescence in the plate reader. We expected serum-starved cells to phagocyte more 
bio particles, because they may be more “hungry” after serum starving. 
Setup 
In one experiment (ch11-001) cells were incubated over night (16 hours) as described 
above either with or without FBS in the Medium. The next day they were stimulated 
with or without 100 bio particles/cell for two hours. After quenching, washing, and 
fluorescence measuring was performed as previously described. Conditions were in 
triplicates. 
Results 
We could observe an increase of fluorescence of more than 100% in both conditions, 
p <0.0001. No difference was observed between serum-starved and not-serum-
starved cells for both, absolute values and the relative change of fluorescence (no 
figure shown). 
Conclusion 
We could confirm that RAW 264.7 macrophages phagocytize bio particles. Serum 
starving, however, had no effect on the phagocytic properties of the cells in this 
setup.  
Additionally, we observed relatively high fluorescence from the plate itself – 
approximately 50% of the maximum signal. Taking this into account there was no 
baseline fluorescence from the cells themselves.  
This plated dependent fluorescence could not be eliminated completely, despite 
using different cell culture plates. 
4.4.2 RAW 264.7 phagocyte bio particles in a dose and time dependent manner, 
and may be saturated with 1000 bio particles per cell 
Initially we planned to do further experiments with saturated macrophages. Therefore 
we searched for the saturating concentration of bio particles. We expected, that the 
phagocytic properties of macrophages have certain limits, i.e. we expected that the 
phagocytosis of macrophages could be saturated by a sufficiently high concentration 
of bio particles, and by a sufficiently long stimulation time.  
Hypothesis 
The phagocytosis of macrophages with bio particles increases with concentration of 
bio particles and stimulation time, but reaches a plateau of fluorescence at a certain 
bio particle concentration and stimulation time. This plateau shows the phagocytic 
saturation of macrophages. 
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Setup 
Three experiments were performed to examine this question.  
Once (ch11-002) macrophages were stimulated with 100 BP/cell for 30, 60, 90, 120, 
150, and 180 min (triplicate samples, figure 14), and with 10 and 1000 BP/cell for 30 
and 120 min (not shown in the figure).  
Once (ch11-004) macrophages were stimulated for 2.5 hours with 0, 100, 200, 400, 
600, 800, and 1000 BP/cell (duplicate samples, figure 13).  
Once (ch11-003) macrophages were stimulated with 100 and with 1000 BP/cell for 
30, 60, 90, 120, 150, and 180 min (triplicate samples, but duplicate samples for 150 
and 180 min). 
Results 
Experiments showed significant (p <0.05) and clearly relevant increase of 
fluorescence (i.e. phagocytosis) after stimulation with increasing bio particle 
concentration. The increase was almost linear and did not show any plateau (figure 
13). 
After stimulation with 100 BP/cell, a time dependent increase of fluorescence could 
be detected, which was for all conditions significant (p < 0.05) compared to the 
samples with 30 min stimulation time, and significant for most conditions, compared 
to their respective neighbors (figures 14 and 15). 
After stimulation with 1000 BP/cell, no significant time dependence of phagocytosis 
could be shown, as the standard deviations became larger (figure 15). 
 
Figure 13: ch11-004_2 Detected fluorescence by plate reader after stimulation for 2.5 hours with 
different BP concentrations. 
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Figure 14: ch11-002_1 Detected fluorescence by plate reader after stimulation with 100 BP/cell for 30 
to 180 min.  
 
 
Figure 15: ch11-003_1 Detected fluorescence by plate reader after different BP concentrations and 
stimulation times.  
Conclusion 
A saturation concentration of extracellular bio particles was searched with the 
intention to perform further experiments using saturated macrophages. The goal was 
to examine whether saturated macrophages can be stimulated to increase their 
phagocytosis, or to lower their saturation dose, respectively. A saturation 
concentration would be visible as a plateau effect of the fluorescence level beginning 
at the saturation dose. 
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When cells were stimulated with 100 BP/cell, these experiments show no evidence of 
a time dependent plateau, i.e. of a saturation of the phagocytosis after 3 hours of 
stimulation with bio particles. 
When cells were stimulated for 2.5 hours with increasing bio particle concentration, 
the results show no evidence of a dose dependent plateau yet. 
There may be a sign for a plateau effect after 2 hours of phagocytosis with 1000 
BP/cell (figure 15). But because of the very wide standard deviations, this observation 
needs to be interpreted carefully. For a certain conclusion of this effect, the same 
experiment, additionally with even longer stimulation times should be repetitively 
performed to achieve smaller standard deviations.  
After these experiments, we decided, also for economic reasons, not to search further 
for a phagocytic saturation of macrophages, and therefore not to use saturated cells 
for the future experiments. 
4.4.3 ATP has no effect on phagocytosis of RAW 264.7 macrophages 
In the first series of preliminary experiments with primary Kupffer cells we could show, 
that extracellular ATP and other nucleotides diminish cytokine secretion. As 
explicated in the background chapter, Elliott (Elliott, 2009) could demonstrate a more 
efficient recruitment of macrophages after pre-treatment with ATP and other 
nucleotides. Marques-da-Silva (Marques-da-Silva, 2011) could increase phagocytosis 
of latex beads by macrophages with ATP and other nucleotides. We aimed to 
reproduce these results in our experimental setting, using RAW 264.7 cell culture 
macrophages. 
Hypothesis 
Extracellular ATP increases phagocytosis of fluorescence labeled bio particles by 
RAW 264.7 cell cultured macrophages. The increased phagocytosis can be measured 
using a fluorescence plate reader. 
Setup 
The above hypothesis was tested in three experiments (ch11-004/005/008). Cells 
were treated or pre-treated with different concentrations of ATP and stimulated with 
different concentrations of bio particles, before fluorescence was measured. In detail:  
Once (ch11-004), cells were pre-treated for 30 min with ATP 0.125 µM, 0.25 µM, 1.25 
µM, 2.5 µM, 3.75 µM, 5 µM, 6.25 µM, 12.5 µM, before the stimulation with 100 and 
200 BP/cell for 2.5 hours (conditions in triplicates, figure 16). 
Once (ch11-005), cells were pre-treated for 30 min with ATP 0 µM, 0.125 µM, 0.25 
µM, 1.25 µM, 2.5 µM, 3.75 µM, 5 µM, 6.25 µM, 12.5 µM, 25 µM, 50 µM, and 250 µM 
before the stimulation with 100 BP/cell for 2.5 hours. Additionally cells were treated 
with ATP 0.25 µM, 2.5 µM, and 25 µM ATP without stimulating with bio particles 
afterwards, to exclude a fluorescing effect of ATP itself (samples in quadruplicates, no 
figure shown). 
Once (ch11-008), ATP 0, 100, 500 and 1000 µM was added immediately prior to the 2 
hours stimulation with 100 BP/cell (samples in quadruplicates, figure 17). 
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Results 
None of the experiments showed consistent and/or significant effect of extracellular 
ATP on phagocytosis of bio particles, see figures 16 and 17. 
 
Figure 16: ch11-004_1 Detected fluorescence by plate reader after pre-stimulation with different 
extracellular ATP concentrations and 100 and 200 BP/cell.  
 
 
Figure 17: ch11-008 Fluorescence after stimulation with different concentrations of extracellular ATP 
and 100 BP/cell. 
Conclusion 
We could exclude ATP itself as a possible biasing factor on our assay by showing 
that ATP itself had no effect on the fluorescence signals (no figure shown). 
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Again we could not reproduce the effect of ATP on phagocytosis, which others 
(Marques-da-Silva, 2011), (Elliott, 2009) published before. Extracellular ATP had no 
effect even at higher concentrations on phagocytosis in our settings.  
Either the used RAW 264.7 cells are not sensible to extracellular ATP concerning their 
phagocytic properties, or small variations in phagocytosis that are generated cannot 
be detected in our settings. 
In one experiment reveal some increased phagocytosis in response to ATP-treatment 
at even lower concentrations may be of interest for further investigations. 
Instead of performing the same experiment again and again with different slight 
variations, searching for an effect, we decided to change the detecting methods in 
favor of flow cytometry, a more precise instrument to detect smaller variations. 
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4.5 U-937 – results of individual experiments 
4.5.1 Flow cytometry 
Using flow cytometry we can measure the same fluorescence labeled bio particles 
used for the previous experiments. In contrast to a plate reader, which measures the 
fluorescence of all the cells in a cell culture well together, flow cytometry will measure 
the fluorescence of thousands of single cells individually. Additionally it is possible to 
measure other properties of the cells.  
This technique gives the possibility to select only the viable populations of the cells 
from the experiment and to calculate a mean value of the fluorescence of many single 
cells. Additionally the graphs generated by flow cytometry can show more detailed 
information on the distribution of phagocytosis within a population of cells.  
Briefly, flow cytometry can potentially generate more detailed and precise information 
about the behavior of a population of phagocytizing cells concerning their “nutritional 
behavior”. We hoped to discover an effect of extracellular nucleotides on 
phagocytosis of macrophages by this more sophisticated method. 
4.5.2 Preliminary experiment – RAW 264.7 and U-937 cells phagocytize bio 
particles, detectable by flow cytometry 
We used a first preliminary experiment (ch11-007) to establish the method for our 
cells. Materials and methods are described above.  
Setup 
For both cell lines RAW 264.7 and U-937, we ran single conditions with and without 
bio particles, with and without serum starving over night, with and without different 
concentration of extracellular ATP as pre-stimulation. 
Results/conclusion 
We could show, that both cell lines, RAW 264.7 and U-937, phagocytize the used bio 
particles. An effect of the pre-stimulations with ATP could not be shown. The not-
serum-starved cells, which were incubated over night with FBS in the culture media, 
showed lesser standard deviations (no figures shown).  
Because the soluble U-937 cells, compared to RAW 264.7 cells which attach to cell 
culture plates and flow cytometry tubes, are much simpler and faster in handling for 
flow cytometry and phagocytize bio particles as well, we decided to use this cell line 
for the future experiments. Also we were not serum starving the cells any more.  
4.5.3 U-937 cells phagocytize bio particles in a dose dependent manner, 
detectable by flow cytometry 
Hypothesis 
The results from the phagocytosis assay with RAW 264.7 cells can be verified with U-
937 cells by flow cytometry. Therefore, U-937 cells will phagocytize bio particles in a 
dose dependent manner. 
Setup 
U-937 cells were stimulated for two hours with different number of bio particles 
reaching from 0 to 100 bio particles per cell (0, 5, 10, 20, 50, 75, 100 BP/cell). 
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Phagocytosis was measured with flow cytometry according to the previously 
described protocol. 
Results 
Analysis of the mean fluorescence values of the fluorescein isothiocyanate positive 
cells (abbreviated with FITC, which is frequently used in flow cytometry) showed an 
increasing value of fluorescence with increasing concentrations of BioParticles.  
The mean (FITC) values increased in a dose dependent manner (figure 18). 
 
Figure 18: ch11-011_1 Mean Fluorescence [arbitrary units] after 2 hours stimulation with different 
amounts of BP/cell 
Conclusions 
Dose dependent increase phagocytosis of bio particles can be shown in flow 
cytometry. The result confirms our findings in the phagocytosis assay. 
For the further experiments we decided to use lower amounts of bio particles. 
Thereby we thought to facilitate the detection of minor changes in phagocytosis due 
to extracellular nucleotides. With higher bio particle concentrations they may be 
overridden by the high amount of bio particles. 
4.5.4 U-937 cells do not phagocytize bio particles in a time dependent manner 
To reproduce another effect shown in the previous experiments with flow cytometry, 
we tested the time dependency of phagocytosis by U-937 cells. 
Hypothesis 
U-937 cells phagocytize bio particles in a time dependent manner. 
Setup 
Cells were stimulated with 10 BP/cell for 15, 30, 60, 120 min. (ch11-014, conditions in 
duplicates) 
Results 
Mean fluorescence was not affected by different stimulation times, even though 
standard deviations were only 1-2% of the fluorescence values (no figure shown). 
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Conclusion 
Unlike in the previous results we gained with RAW 264.7 cells, the phagocytosis of U-
937 cells within the tested settings was not time dependent.  
Instead of further searching of a time dependency with other conditions, we decided 
to continue with experiments to examine the effect of extracellular ATP on 
phagocytosis. 
4.5.5 Extracellular ATP does not alter phagocytosis of U-937 cells 
Hypothesis 
Extracellular ATP increases phagocytosis of U-937 cells. 
Setup 
Altogether we performed five experiments with extracellular ATP.  
Cells were pre-treated for 30 min with 0, 0.01, 0.1, 1, 10, 100 µM ATP, then 
stimulated for two hours with 50 BP/cell (ch11-011, triplicate samples), or with 2.5, 5, 
and 10 BP/cell (ch11-012, duplicate samples). In another experiments cells were pre-
treated for 30 min with 10, 100, 400 µM ATP, then stimulated with 10 BP/cell for two 
hours (ch11-013, triplicate samples).  
In two other experiments, cells were pre-treated for 30 min with ATP 50 µM (only 
ch11-016), 100, and 300 µM (ch11-016 and 017) before a 30 min stimulation with 
both 5 and 10 BP/cell (ch11-016 in triplicate samples, ch11-017 in duplicate 
samples). 
Results 
A significant effect of ATP on phagocytosis was not detected (as example: figure 19, 
from the experiment ch11-012). Neither did the distribution of fluorescence within the 
population of cells change, as determined in the graphs from flow cytometry (no 
figures shown). 
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Figure 19: ch11-012_2 Mean Fluorescence of FITC positive cells after pre-stimulation for 30 min with 
different concentrations of extracellular ATP and stimulation for 2 hours with different concentrations of 
bio particles. 
Conclusion 
ATP has no effect on phagocytosis of bio particles by U-937 cells in the examined 
conditions. These results with human cell culture monocytes/macrophages are 
contradictory to the published results by Marques-da-Silva with murine primary 
macrophages (Marques-da-Silva, 2011). 
The differences between the different cells used are a possible explanation of the 
different results. 
4.5.6 Extracellular ATPγS does not alter phagocytosis of U-937 cells 
Another reason why ATP has no effect on the used cells is, that ATP is hydrolyzed by 
ectonucleidases of U-937 cells. To exclude, that the hydrolysable properties of ATP is 
not responsible for false negative results, we performed the same experiments with 
ATPγS, too. 
Hypothesis 
Extracellular ATPγS increases phagocytosis of U-937 cells. 
Setup 
Altogether four experiments were performed answering this question. 
In one experiment cells were pre-treated for 30 min with 10, 100, 400 µM ATPγS, then 
stimulated with 10 BP/cell for two hours (ch11-013, triplicate samples). In one 
experiment cells were pre-treated for 30 min with 0, 1, 10, 100 µM ATPyS and then 
stimulated with 10 BP/cell for 15, 30, 60, 120 min (ch11-014, conditions in 
duplicates).  
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In two other experiments, cells were pre-treated for 30 min with ATPγS 50 µM (only 
ch11-016), 100, and 300 µM (ch11-016 and 017) before 30 min stimulation with both 
5 and 10 BP/cell. (ch11-016 in triplicate samples, ch11-017 in duplicate samples) 
Results 
No significant effect of ATPγS on phagocytosis could be shown (no figure shown).  
Conclusion 
Also with the non-hydrolysable ATPγS, no purinergic effect on phagocytosis could be 
demonstrated in our setting. 
4.5.7 Apyrase, ADP, and UTP do not alter phagocytosis of U-937 cells 
To further search for purinergic effects on phagocytosis of U-937 cells, we used two 
other nucleotides, i.e. ADP and UTP. Additionally we used Apyrase, which should 
degrade possible extracellular base level ATP and therefore lower its effect. 
Hypothesis 
Extracellular ADP and UTP increase phagocytosis of U-937 cells. Apyrase decreases 
phagocytosis of U-937 cells. 
Setup 
In two experiments (ch11-016 in triplicates, ch11-017 in duplicates) cells were pre-
treated for 30 min with 100, 200, and 300 µM ADP and with 100 and 300 µM UTP and 
then stimulated for 30 min with 5 and 10 BP/cell. 
In one experiment (ch11-013, in triplicates) cells were pre-treated with 0.01, 0.1, 1, 10 
U/l Apyrase for 30 minutes and then stimulated with 10 BP/cell for 2 hours.  
Results 
Neither ADP, nor UTP, nor Apyrase could significantly and consistently alter 
phagocytosis of U-937 cells (no figure shown). 
Conclusion 
A purinergic effect with other nucleotides than ATP (i.e. ADP and UTP) also could not 
be shown. Additionally an effect of possible base level ATP (e.g. released by the cell 
culture itself) could not be abolished by hydrolysis using Apyrase. 
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4.6 Summarized results 
Phagocytosis of bio particles by RAW 264.7 murine macrophages with different 
exposure concentrations of bio particles (figure 13), different exposure times (figures 
14, 15), and in response to ATP (figures 16, 17) has been measured by a plate reader 
fluorescence assay. 
Phagocytosis of bio particles by U-937 human monocytes/macrophages with 
different exposure concentrations of bio particles (figure 18) and in response to ATP 
(figure 19) and other nucleotides and apyrase (no figures) has been measured by flow 
cytometry. 
4.6.1 Results from the experiments with RAW 264.7 cells using the plate reader 
phagocytosis assay. 
Summarized, from the first series of experiments performed as described above with 
RAW 264.7 cells and a phagocytosis assay, measured in a fluorescence plate reader, 
we gained the following findings: 
- Macrophages from the RAW 264.7 cell line phagocyte fluorescence labeled bio 
particles. The phagocytosis is not influenced by serum starvation. 
- The amount of phagocytized bio particles is dependent on both exposure time 
and concentration of the exposed bio particles. A saturating effect (a plateau) 
could not be demonstrated with low concentration of bio particles.  
- The phagocytosis of bio particles by RAW 264.7 macrophages cannot be 
influenced by extracellular ATP in an extend that could be measured by the 
fluorescence of entire wells. 
4.6.2 Results from the experiments with U-937 cells using flow cytometry 
In summary, from the second series of experiments performed as described above 
with U-937 cells phagocytizing FITC labeled bio particles, we gained the following 
findings, measured with flow cytometry: 
- Monocytes/Macrophages from the U-937 cell line phagocyte fluorescence 
labeled bio particles.  
- The amount of phagocytized bio particles is dependent on the bio particle 
concentration. An effect of exposure time could not be demonstrated, but 
would need further investigation for more precise statements.  
- Extracellular ATP cannot significantly influence the phagocytosis of bio 
particles by U-937 monocytes/macrophages. 
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5 Discussion 
5.1 Kupffer cell release of TNFα  upon stimulation with LPS can be 
inhibited by extracellular nucleotides  
We could reproduce, that LPS has a stimulating effect on Kupffer cells, leading to a 
cytokine (i.e. TNFα) release and other effects (Decker, 1990) (Lin, 2005). 
Especially we could demonstrate, that extracellular nucleotides, in particular ATP, can 
lower and even abolish cytokine – i.e. TNFα – release of murine Kupffer cells, in 
response to bacterial LPS. Furthermore we could show, that the effect of ATP on 
TNFα-release is dependent on a stimulation of Kupffer cells, e.g. with LPS. 
 
All nucleotides used, i.e. ATP, ATPγS, ADP, UTP, and BzATP, showed similar 
qualitative effects but were effective in different concentrations. 
By the use of ATPγS we could show that the response to extracellular ATP is 
mediated via activation of P2 type receptors and not in response to 
dephosphorylated nucleosides such as AMP or Adenosine. We conclude, that the 
effect is, at least partly, mediated by one of the ATPyS dependent receptors P2X2, 
P2X5, P2Y1, P2Y11, P2Y12, or P2Y13 receptors.  
Because of the shown effect of BzATP, we conclude, that the effects of ATP are, at 
least partly, mediated by one of the BzATP dependent receptors P2X1, P2X3, P2X7 
or P2Y11 receptor. P2Y11 is therefore the known common receptor of both agonists.  
Additionally, based on the results we achieved with UTP, effects of ATP are, at least 
partly, mediated by one of the UTP dependent receptors P2Y2, P2Y4, P2Y6, P2Y11. 
UTP is only an agonist for P2Y receptors, but not for P2X receptors. Therefore we 
propose that G-protein coupled signaling is a key mechanism of how extracellular 
nucleotides impact on TNF release. 
Experiments with the P2 receptor antagonist Suramin, however, were inconclusive. 
A potential common intersection of the receptors of ATPγS, BzATP, UTP, and 
Suramin is P2Y11 receptor. I therefore postulate, that P2Y11 is a relevant or even a 
key receptor for purinergic signaling in Kupffer cells. 
All of the above experimental data and conclusions and the fact that three of the used 
nucleotides – ATP, ATPγS, and BzATP – showed very clear effects on TNFα-release 
by Kupffer cells motivates to keep searching for the receptors mediating this effect. 
P2Y11 would be my favorite next target. 
However, by the performed experiments, involvement of other P2Y G-protein coupled 
receptors, or even of P2X ion-channel receptors, cannot definitely be excluded. 
5.1.1 Comparison to other publications 
Searching the literature, a clear and consistent effect of extracellular ATP on TNFα-
release of macrophages is not yet established. Both increased and decreased TNFα-
release (with and without stimulation with LPS) has been shown (Rayah, 2012) (Gabel, 
2007). Haskò et al showed similar results as we do, i.e. a dose dependent decrease of 
TNFα in response to ATP and other nucleotides by murine peritoneal macrophages 
(Haskò, 2000). Lambert et al demonstrated a decrease in LPS-induced TNFα release in 
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human microglia and macrophages in response to ATP (Lambert, 2010). Additionally, 
in the same paper, they describe increased migration of microglia in response to 
extracellular ATP. On the other hand Hide et al describe an increase of TNFα release 
in response to ATP in rat microglia cell cultures (Hide, 2000). 
Although, in contrast to our results, the results of Sakaki et al show an increase of 
cytokine release in response to ATP, Sakaki et al identify P2Y11 receptor to be 
relevant in the autocrine regulation of macrophage activation (Sakaki, 2013). In vitro, 
they demonstrated a P2Y11 dependent increase of IL-6 release by LPS-stimulated 
macrophages in response to ATP. Sakaki et al suppressed blood serum levels of 
TNFα, IL-6 and other cytokines using an antagonist of P2Y11 receptor in mice 
stimulated with intraperitoneal administration of LPS (Sakaki, 2013). These results are 
supporting our results with which we propose that P2Y11 mediated anti-inflammatory 
effects of extracellular ATP. 
5.1.2 Methodical weaknesses of the study 
Further discussion of this work shows also methodical weaknesses, which are to be 
addressed, when further experiments are performed:  
Main deficits are on the one hand, that Kupffer cells were not counted and/or 
incubated at a standardized concentration of cells per well. Therefore no statements 
can be made neither about the concentration of nucleotides per cell, nor about the 
amount of TNFα released per cell with specific stimulations. Additionally, different 
experiments with same settings cannot be taken together to achieve higher 
significance in the statistical evaluation. On the other hand, only few (sometimes just 
one) experiments have been performed for each setting. Therefore this work has to be 
viewed as a series of interesting preliminary experiments, and no final conclusions 
can be drawn before every single experiment has been reproduced.  
 
Furthermore, viability of the cells after the assay has not been tested consequently. 
Theoretically, the changes in TNFα release could be due to ATP and LPS induced cell 
death by necrosis or apoptosis via P2X7 receptor, as it has been described (Le 
Feuvre, 2002) (Di Virgilio, Cytolytic P2X purinoceptors, 1998). If this would be the case, 
we would have shown a dose dependent cell toxicity of ATP in co-stimulation with 
LPS. To exclude that, experiments needed to be reproduced and completed with a 
reliable cell viability assay or with pharmacologically or genetically antagonizing of 
P2X7. Since on rat Kupffer cells no P2X7 receptor has been shown (Xiang, 2006), this 
theory seems rather improbable. 
5.1.3 Conclusion 
However, we could show a decrease of TNFα in the supernatants of primary murine 
LPS-stimulated Kupffer cells after co-stimulation with nucleotides. As described 
above, we postulate a P2-receptor modulated pathway is responsible for this effect, 
possibly P2Y11. But further research needs to be done to explore the responsible 
receptors and intracellular pathways generating the observed effect. 
Taking together our results and the mentioned publications, we conclude that 
extracellular nucleotides at least in the liver can possibly have an effect on the 
immune system, and that this effect – at least partly – is mediated by cytokine release 
of Kupffer cells. 
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A next step could be a systematic use of other more specific P2-receptor agonists 
and antagonists in different combinations to restrict the possible receptors for closer 
investigation. More sophisticated techniques, such as genetically knocked out cells 
for specific receptors, or others, could follow. 
But as introduced in the first chapter, in this work we further searched for other 
effects of extracellular nucleotides, which modulate the immune system and are 
presented below. 
5.2 Effect of extracellular Nucleotides on phagocytosis of fluorescein 
labeled inactivated E. coli bio particles by RAW 264.7 and U-937 cell 
culture macrophages. 
We could demonstrate phagocytosis of fluorescence labeled bio particles by both 
macrophage cell lines RAW 264.7 and U-937. We also showed a dose dependency of 
phagocytosis. The amount of phagocytized bio particles is depending primarily on the 
concentration of bio particles available to the macrophages. A saturating 
concentration could not be determined. 
Depending on the cell type, phagocytosis of bio particles could also be increased by 
longer exposure times of the cells. While RAW 264.7 cells showed a continuous 
increase of phagocytosis with time, this effect was not reproducible within the same 
exposure times in U-937 cells. 
However, in all our settings, both with RAW 264.7 and U-937 cell lines, we repetitively 
could not reproduce an effect of extracellular nucleotides on phagocytosis of 
macrophages, as published by other authors (Marques-da-Silva, 2011) (Elliott, 2009). 
Our results with murine and human cell culture macrophages and 
monocytes/macrophages are contradictory to the ones of Marques-da-Silva with 
murine primary macrophages (Marques-da-Silva, 2011).  
We therefore conclude, that extracellular nucleotides, especially ATP, have no effect 
on phagocytosis by RAW 264.7 and U-937 cells. Since, others have showed an effect 
of extracellular nucleotides on phagocytosis in different conditions, it remains to be 
explored, which factors influence the effect of ATP on phagocytosis.  
5.2.1 Comparison to other publications 
Different explanations are imaginable for the noted discrepancy, either looking for 
differences within the cells or in the methods used in the different experiments. 
A possible explanation of the different results are differences between the different 
cells used, such as e.g. the difference between primary and cell culture macrophages, 
or between murine and human macrophages. Different macrophages may have 
different receptor expressions. Marques-da-Silva et al propose P2X1, P2X3, P2X7, 
and/or P2Y1 receptors to be responsible for their described effects (Marques-da-Silva, 
2011). The cells we used may lack these receptors. Further genetical, immunological, 
or other analyses needed to be done to compare the different cell types for these 
receptors to determine whether the existence or lack of one of these receptors may 
be relevant to explain differences in the obtained results. 
Theoretically otherwise, the changes in phagocytosis could be due to ATP and LPS 
induced cell death by necrosis or apoptosis via P2X7 receptor, as it has been 
described (Le Feuvre, 2002) (Di Virgilio, Cytolytic P2X purinoceptors, 1998). If some of 
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the macrophages underwent phagocytosis in response to ATP, surviving 
macrophages would have more bio particles per cell available for phagocytosis. This 
would explain higher phagocytosis per cell. This effect may not be relevant in the cell 
culture cells we used, that are derived from tumor cells. Tumor cells are known to 
have lesser tendency to undergo apoptosis. But until proven, this theory remains 
hypothetic.  
Possibly also, in our experiments macrophages may be not sufficiently saturated with 
bio particles.  Insufficiently saturated cells would phagocyte all available bio particles, 
independent of any co-stimulation with nucleotides. If this was the case, even if 
nucleotides had an effect, it could not be demonstrated, because of the insufficient 
saturation. The fact, that a saturation of phagocytosis could not be demonstrated, 
even using 1000 bio particles per cell, indicates very high capacities of phagocytosis 
and supports the theory of an insufficient saturation. Possibly, the affinity of 
macrophages is higher for bio particles than for latex beads. This would explain, why 
in our settings cells were insufficiently saturation, compared to the settings with latex 
beads used by other groups. Otherwise, the fact, that phagocytosis is time 
dependent in RAW 264.7 cells, is contradictory to this theory.  
Additionally, it has been shown, that phagocytosis by macrophages is depending on 
size of the particles and on the opsonizing density, i.e. on the amount of Fc ligands 
(Pacheco, 2013). On the other hand, the same work showed, that the phagocytosis of 
larger particles was lesser, and could not be influenced by Fc density on their surface. 
Bio particles we used may be larger and therefore less phagocytized than latex beads 
used by other. Additionally phagocytosis of larger particles seems to be less prone to 
modulation than smaller particles. This could explain, why other groups could 
modulate phagocytosis of latex beads while for us it was not possible to modulate 
phagocytosis of bio particles.  
5.2.2 Conclusion 
However, various factors probably have relevant influence on the characteristics of 
either nucleotide signaling or phagocytic properties of macrophages, such as type 
and derivation of macrophages. Additionally, speed or capacity of phagocytosis, or 
both, seem to depend on type and derivation of macrophages as well as size and 
other properties of the phagocytized particles. 
5.3 General conclusion 
Extracellular nucleotides act as signaling molecules on cells and can modulate cell 
functions (Eltzschig, Sitkovsky, & Robson, 2012). An effect of extracellular nucleotides is 
postulated for years and has been shown in many different studies (Eltzschig, 
Sitkovsky, & Robson, 2012) (Burnstock, Purinergic signalling: Its unpopular beginning, its 
acceptance and its exciting future , 2012) (Bours, 2006). 
Our experiments with primary Kupffer cells showed, that various extracellular 
nucleotides, especially ATP and ATPγS, and other P2 receptor agonists (i.e. BzATP) 
have an inhibiting effect on TNFα release of LPS-stimulated Kupffer cells.  
On the other hand, Sakaki et al describe suppressed blood serum levels of TNFα, IL-
6 and other cytokines using an antagonist of P2Y11 receptor in mice stimulated with 
intraperitoneal administration of LPS (Sakaki, 2013). In the same paper, they describe 
a pro-inflammatory polarization of peritoneal and spleen macrophages in LPS-
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induced sepsis in mice in response to ATP, that could be suppressed using an 
antagonist of P2Y11 receptor. Their data also pointed out the importance of 
purinergic signaling in sepsis by changes in cytokine release. But in contrast to us, 
they conclude ATP to have a pro-inflammatory effect via autocrine regulation of 
macrophages. 
The discrepancies between the different studies shows the complexity of the topic 
and further research is required to better understand the effects of purinergic 
signaling in sepsis. However, we conclude, that one important mechanism how 
extracellular nucleotides modulate the immune system is via the cytokine release of 
Kupffer cells and possibly other macrophages in the body, too.  
The relevance of various in vitro effects in an entire organism in vivo will need further 
research, to determine, whether nucleotides in vivo have pro- or anti-inflammatory 
effects. Also, the effect of extracellular nucleotides on other macrophages in the 
body, the knowledge about responsible receptors, detailed signaling pathways, and 
possibly other nucleotides, needs further investigation. 
Our other experiments with cell culture macrophages – in contrast to published data 
from other authors – showed no sign of an effect of extracellular nucleotides on the 
phagocytic properties of macrophages. If further research seems required the 
appropriate conditions have to be explored in detail. However, an effect of 
extracellular nucleotides on phagocytosis still seems probable. Possibly this effect is 
not very distinct or not intrinsic to all species of macrophages, so that our cells didn’t 
show an effect. 
Finally, we show some evidence that extracellular nucleotides are a – possibly 
important – factor in the immune system and especially inflammatory response to 
gram-negative bacterial infection and modulate inflammatory response from 
macrophages. We could demonstrate an inhibition of TNFα release in response to 
extracellular ATP but no effect on phagocytosis. Further effects of extracellular 
nucleotides on the immune system, their signaling mechanisms, and their relevance in 
vivo need further experimental research both in vitro and in vivo before being able to 
discuss and evaluate possible clinical implementations.  
5.3.1 Therapeutic targets of purinergic signaling 
The clinical relevance of purinergic signaling can theoretically be investigated in every 
context of inflammation. Especially in the context of sepsis due to bacteremia, which 
stands for a generalized inflammation. It may be possible to reduce clinical severity of 
sepsis by altering the release of inflammatory cytokines in response to bacteremia. 
Whether ATP, or other mediators in purinergic signaling are the key mediators still 
needs to be shown in future.  
Lecut et al describe a higher susceptibility of P2X1 -/- knockout mice to LPS-induced 
sepsis, even if they could not demonstrate an altered cytokine release (Lecut, 2012). 
Together with their other results, they conclude that P2X1 ion channel receptors play 
a protective role in endotoxemia by negatively regulating systemic neutrophil 
activation.  
Various other diseases are associated with deregulated inflammation and can 
therefore potentially be addressed by immunomodulation via purinergic signaling. In a 
perspective article Arulkumaran et al describe different renal diseases where 
purinergic signaling has pathological effects (Arulkumaran, 2013).  
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In allergic asthma for example, purinergic signaling has also been named as a 
potential therapeutic target by Idzko et al. In their study they describe an increased 
ATP level in the airways of asthmatic patients and mice (Idzko, 2007). In a murine 
model of asthma they could reduce various cardinal features of asthma by either 
degrading ATP in the airways using apyrase, or by treating mice with different P2 
receptor antagonists. 
Surgery is a stressful event for the human organism, and perioperative stress can lead 
to major changes of hemodynamic status of patients, and to ischemic stress of 
organs for different reasons. This makes perioperative organ protection to another 
relevant topic in the further research of the therapeutic use of purinergic signaling. 
Eltzschig (Eltzschig H. , Targeting Purinergic Signaling for Perioperative Organ Protection, 
2013) summarizes different approaches to target purinergic signaling for perioperative 
organ protection. 
Ischemia and reperfusion itself is known as a major stressful factor for organs in 
different settings such as cerebral or myocardial infarction, but also in the 
perioperative period, leading to different inflammatory changes (Eltzschig H. , Ischemia 
and reperfusion—from mechanism to translation , 2011). In his profound review, Eltschig 
names purinergic signaling as one of many mechanisms in the regulation of ischemia 
and reperfusion injuries and points out potential therapeutic approaches in this 
context. 
5.3.2 Questions for the future research 
As pointed out, modulation of inflammation and immune system by purinergic 
signaling is a possible target for future therapeutic approaches of various diseases. 
But until a broad and safe clinical use can be achieved, knowledge about purinergic 
signaling and its effects on inflammation and the immune system needs to become 
much more profound. Various questions yet need to be answered, for example: 
- Which cells changes their inflammatory properties in response to extracellular 
nucleotides and in what is the effect?  
- Which cytokines are up- or downregulated by which cells? 
- Which cytokine patterns lead to an up- or downregulation of inflammatory 
responses in the tissue? 
- What is the clinical consequence and benefit of a modulation of purinergic 
signaling in the human organism? 
- Do extracellular nucleotides have effects only in autocrine/paracrine signaling 
or can their effects be used systemically. 
- Do extracellular nucleotides only play relevant roles in acute situations, such as 
allergic asthma or ischemia and reperfusion, or can they be used also in 
chronic inflammatory states? 
- What are the dangers of immunomodulation via purinergic signaling? 
Obviously, many questions remain to be answered, but the enormous amount of 
promising research encourages to further exploring the possibilities opened by 
purinergic signaling. 
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